----

|  | [X]        Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
|--|-------------------------------------------------------------------------------------------------------------------------------|

|  | [  ]      Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
|--|----------------------------------------------------------------------------------------------------------------------------------|

| Delaware                                             |   | 62-1117144          |
|------------------------------------------------------|--------|---------------------|
| (State or other jurisdiction of                      |   | (I.R.S. Employer    |
| incorporation or organization)                       |   | Identification No.) |
| 701 Cool Springs Boulevard, Franklin, TN  37067 |
| (Address of principal executive offices) (Zip code)  |
| (615) 614-4929                                       |
|------------------------------------------------------|
| (Registrant's telephone number, including area code) |
| Securities registered pursuant to Section 12(b) of the Act: |
|-------------------------------------------------------------|
| Title of each class                     |   | Name of each exchange on which registered |
|-----------------------------------------|--------|-------------------------------------------|
| Common Stock - $.001 par value, and     |   | The NASDAQ Stock Market LLC               |
| related Preferred Stock Purchase Rights |   |                                      |
| Yes  ¨ |    No  x |
|------------------|-------------------------|
| Yes  ¨ |    No  x |
|------------------|-------------------------|
| Yes   x |    No  ¨ |
|-------------------|------------------------------|

----

| Yes   x |    No   ¨ |
|-------------------|------------------------------------|
| Large accelerated filer  ¨ | Accelerated filer  x | Non-accelerated filer  ¨ | Smaller reporting company  ¨ |
|--------------------------------------|---------------------------|------------------------------------|----------------------------------------|
| Yes  ¨ |    No  x |
|------------------|-------------------------|

----

|             |     |                                                                                           | Page   |
|------------------|----------|------------------------------------------------------------------------------------------------|--------|
| Explanatory Note |     | 4                                                                                              |
| Part III         |     |                                                                                           |   |
|             | Item 10. | Directors, Executive Officers and Corporate Governance                                         | 4      |
|             | Item 11. | Executive Compensation                                                                         | 10     |
|             | Item 12. | Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters | 57     |
|             | Item 13. | Certain Relationships and Related Transactions, and Director Independence                      | 62     |
|             | Item 14. | Principal Accounting Fees and Services                                                         | 63     |
| Part IV          |     |                                                                                           |   |
|             | Item 15. | Exhibits, Financial Statement Schedules                                                        | 64     |

----

| Item 10. | Directors, Executive Officers and Corporate Governance |
|----------|--------------------------------------------------------|

| John W. BallantineFormer Executive Vice President and Chief Risk Management Officer of First Chicago NBD Corporation | Age 68  | Director since 2003  |
|----------------------------------------------------------------------------------------------------------------------|--------------|---------------------------|

----

| Kevin G. WillsManaging Director and Chief Financial Officer of AlixPartners, LLP  | Age 48  | Director since 2012  |
|----------------------------------------------------------------------------------------|--------------|---------------------------|
| Daniel J. EnglanderManaging Partner of Ursula Capital Partners | Age 45  | Director since March 2014  |
|----------------------------------------------------------------|--------------|---------------------------------|

----

| C. Warren Neel, Ph.D.Former Executive Director of the Center for Corporate Governance at the University of Tennessee | Age 75  | Director since 1991  |
|----------------------------------------------------------------------------------------------------------------------|--------------|---------------------------|
| Jay C. Bisgard, M.D.Former Director of Health Srvices at Delta Air Lines, Inc. | Age 71  | Director since 2003  |
|--------------------------------------------------------------------------------|--------------|---------------------------|
| Mary Jane England, M.D.Professor at the Department of Community Health Sciences at the Boston University School of Public Health; Former President of Regis College | Age 75  | Director since 2004  |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|---------------------------|

----

| John A. WickensFormer National Health Plan President of UnitedHealth Group | Age 57  | Director since 2007  |
|----------------------------------------------------------------------------|--------------|---------------------------|
| William D. NovelliProfessor at the McDonough School of Business at Georgetown University;  Former Chief Executive Officer of AARP | Age 72  | Director since 2009  |
|----------------------------------------------------------------------------------------------------------------------------------------|--------------|---------------------------|

----

| Ben R. Leedle, Jr.President and Chief Executive Officer of the Company | Age 53  | Director since 2003  |
|------------------------------------------------------------------------|--------------|---------------------------|
| Alison Taunton-Rigby, Ph.D.Former Chief Executive Officer of RiboNovix, Inc. | Age 70  | Director since 2005  |
|------------------------------------------------------------------------------|--------------|---------------------------|
| Donato TramutoChief Executive Officer and Chairman of Physicians Interactive | Age 57  | Director since 2013  |
|------------------------------------------------------------------------------|--------------|---------------------------|

----

----

| Item 11. | Executive Compensation |
|----------|------------------------|

|  Name         |  Position                                     |
|--------------------|----------------------------------------------------|
|               |                                               |
| Ben R. Leedle, Jr. | President and Chief Executive Officer              |
| Alfred Lumsdaine   | Executive Vice President, Chief Financial Officer  |
| Peter Choueiri     | President, Healthways International                |
| Michael Farris     | Executive Vice President, Chief Commercial Officer |
| Glenn Hargreaves   | Chief Accounting Officer                           |
| Mary Flipse        | Senior Vice President, General Counsel             |

----

----

| Executive Compensation Program Changes (2013 and 2014)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  Incentive Design                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |  Governance |
| ·    Revised Peer Group (2013 and 2014): Established a revised peer group for 2013 and a further revised peer review group for 2014 for purposes of evaluating the executive compensation program.  The revised group for 2014 includes relevant industry peers with comparable revenues and market capitalization to Healthways.·    Incentive Caps (2013): Added a cap to annual and long-term incentives for our executive officers.·    Lower CEO Total Compensation (2014): Targeted CEO total compensation at the 2014 Peer Group median which results in a 30% reduction in target total compensation pay opportunity in 2014 as compared to 2013.·    Performance-Based Equity (2014): Adopted an equity-based long-term incentive program (subject to availability of shares under the 2007 Stock Incentive Plan, as amended (the "2007 Plan") or the new 2014 Stock Incentive Plan (the "2014 Plan"), if approved by stockholders) with 50% of the grant value subject to risk of forfeiture if pre-defined, multi-year performance objectives are not achieved.·    Long-Term Vesting (2014): Extended the vesting period on the settlement of performance-based awards from 3 years to 4 years to emphasize retention and mitigate risk-taking behaviors during the performance period.·    Multi-Year LTI Performance Period (2014): Extended the long-term incentive performance period from 12 months to a multi-year period to reward sustained performance. ·    No Above-Target Pay Without Superior Total Shareholder Return Results (2014): Performance-based LTI is capped at target unless annualized total shareholder return ("TSR") during the performance period exceeds 25%. Above-target LTI payout is subject to the incentive caps established in 2013. | ·    Recoupment Policy (2013): Adopted an incentive recoupment policy that permits the Committee, in its discretion, to recover incentive-based compensation from our executive officers in the event of a restatement of our financial results or non-compliance with our Code of Business Conduct to the material detriment of the Company.·    No Change in Control Gross-Ups (2013):  Adopted a policy whereby gross-up payments in connection with excise taxes upon a change in control are prohibited in future employment agreements.·    Anti-Hedging and Anti-Pledging Policies (2013 and 2014): In 2013, adopted a policy prohibiting the hedging of shares of Company stock, and in 2014, adopted a policy prohibiting the pledging of shares of Company stock, by our executive officers and Board members.·    Double-Trigger Vesting Upon a Change In Control (2014): Adopted a policy whereby future equity awards may not accelerate vesting upon a change in control unless the executive is terminated without cause or with good reason within 12 months of the change in control event or the award is not assumed by an acquirer. |

----

| ü | Pay for performance by placing the majority of executive compensation "at risk" through linkage to our financial or market results |
|--------|------------------------------------------------------------------------------------------------------------------------------------|

| ü | Mitigate undue risk by having caps on incentive awards and a recoupment policy with respect to performance-based compensation |
|--------|-------------------------------------------------------------------------------------------------------------------------------|

| ü | Maintain meaningful stock ownership and retention requirements |
|--------|----------------------------------------------------------------|

| ü | Engage an independent compensation consultant who does not provide any other services to the Company |
|--------|------------------------------------------------------------------------------------------------------|

| ü | Require double trigger change in control provisions for acceleration of equity awards in all new equity awards |
|--------|----------------------------------------------------------------------------------------------------------------|

| ü | Balance multiple metrics for short- and long-term incentives |
|--------|--------------------------------------------------------------|

| ü | Seek stockholder feedback on our executive compensation |
|--------|---------------------------------------------------------|

| X | No excise tax gross-ups upon a change in control for employment agreements entered into after February 2013 |
|---|-------------------------------------------------------------------------------------------------------------|

| X | No tax gross-ups on ongoing benefits |
|---|--------------------------------------|

| X | No granting of discounted stock options |
|---|-----------------------------------------|

| X | No repricing of stock options or repurchasing of equity awards without stockholder approval |
|---|---------------------------------------------------------------------------------------------|

| X | No hedging or short sales of Company securities |
|---|-------------------------------------------------|

| X | No pledging of Company securities |
|---|-----------------------------------|

----

| Description             | 2013Target Pay | 2014Target Pay | PercentageChange |
|-------------------------|----------------|----------------|------------------|
|                    |           |           |             |
| Base salary             | $712           | $712           | 0%               |
| Short-term incentive    | $499           | $499           | 0%               |
| Long-term incentive     | $2,672         | $1,500         | -44%             |
|    Total | $3,883         | $2,711         | -30%             |

| · | Annually evaluating the performance of the CEO and other executive officers and recommending to the independent directors of the Board the compensation level, including short- and long-term incentive compensation, for each such person based on this evaluation; |
|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| · | Reviewing and recommending for approval to the Board any changes in executive officer incentive compensation plans and equity-based compensation plans; and |
|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------|

| · | Reviewing and approving all equity-based compensation plans of the Company and granting equity-based awards pursuant to such plans. |
|--------|-------------------------------------------------------------------------------------------------------------------------------------|

----

| · | The Committee seeks to assure that compensation paid to executive officers is fair, reasonable and competitive, and is linked to increasing long-term stockholder value. Only independent directors serve on the Committee. Based on the Compensation Committee Charter, the Compensation Committee may delegate any of its responsibilities to a subcommittee so long as such subcommittee is solely composed of one or more members of the Committee. |
|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| · | Compensation that reflects both individual and Company performance. |
|--------|---------------------------------------------------------------------|

| • | We link employee pay to both individual and Company performance. |
|---------|------------------------------------------------------------------|

| • | When employees assume greater responsibilities, more of their pay is linked to Company performance and stockholder returns through increased participation in equity programs and increased linkage of their short-term and long-term incentive targets to overall Company performance.  Since a significant share of our NEOs' total compensation is based on long-term incentives, their interests are aligned with the long-term interests of our stockholders and the Company. |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| • | We balance pay-for-performance and employee retention.  Even during downturns in Company performance, the compensation program should continue to motivate successful, high-achieving employees. |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| · | Compensation consistent with job responsibility and the market. |
|--------|-----------------------------------------------------------------|

| · | Stockholder input. |
|--------|--------------------|

----

| · | Its compensation philosophy -- to ensure alignment with the principal objectives for compensation; |
|--------|----------------------------------------------------------------------------------------------------|

| · | Our executive compensation policies -- in light of our financial performance, the annual budget, and competitive and best practices; and |
|--------|------------------------------------------------------------------------------------------------------------------------------------------|

| · | The compensation of individual executives -- in light of such executive's performance and the Committee's executive compensation policies for that year. |
|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------|

| · | Assessment of individual performance. |
|--------|---------------------------------------|

| • | At the beginning of each year, the Committee meets with the CEO to review and approve performance objectives for the upcoming year for the CEO and the other NEOs.  After the end of the year, the CEO delivers to the Committee individual performance evaluations and compensation recommendations for each NEO.  The Committee determines compensation adjustments for each NEO based on a variety of factors, such as a competitive compensation analysis, the CEO's and the Committee's assessment of each NEO's individual performance, the Company's performance, and the Committee's judgment based on the NEO's interactions with the Board. |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| • | After the end of the year, the CEO presents to the Committee a self-assessment of his performance for the year based on his established performance objectives.  The Committee conducts a confidential review of the CEO's performance for the previous year and discusses and recommends to the independent directors any compensation adjustment for the upcoming year based on the competitive compensation analysis, its assessment of the CEO's performance in light of the pre-approved performance objectives, the Company's performance, and the level of CEO compensation relative to the other NEOs. |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| · | Assessment of Company performance. |
|--------|------------------------------------|

| • | In addition to each NEO's individual performance, the Committee also considers the Company's overall performance in determining executive compensation.  When evaluating the relationship between the CEO's pay and Company performance, the Committee considers both reported pay (as reflected in the Summary Compensation Table) and realized pay for the CEO in recent years. |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| · | Compensation benchmarking. |
|--------|----------------------------|

| • | The Committee reviews NEO compensation against external references to determine the appropriateness of compensation.  The Committee does not use particular formulas or specific positions within a range to determine compensation levels reflecting the responsibilities of a particular officer position but instead uses external comparisons to provide a point of reference.  The external references may include peer group analysis (see below) and/or commercially available, broad-based, comparative market compensation survey reports developed by independent professional organizations (collectively, the "Survey Reports").  The Survey Reports cover a significant number of companies across a broad range of industries.  To support the Committee's review and evaluation, management, and if applicable, an independent compensation consultant, provides the Committee with information drawn from the Survey Reports.  While the Committee still applies this approach, for 2014, based on stockholder feedback, the Committee targeted CEO total compensation at the 2014 Peer Group median. |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| • | The Committee recognizes that we compete locally and nationally for talent with companies much larger than those included in our compensation peer group.  These larger companies aggressively recruit for the best qualified talent in particularly critical functions.  As a result, to attract and retain talent, the Committee may from time to time determine that it is in the best interests of our Company and stockholders to provide compensation packages that deviate from the external benchmark references. |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| · | Base salaries; |
|--------|----------------|

| · | Short-term cash incentive awards, based on achieving clearly-defined financial targets; and |
|--------|---------------------------------------------------------------------------------------------|

| · | Long-term incentive awards that are based on individual performance and/or the achievement of financial performance and/or business goals.  To focus our executives on the Company's long-term sustainable performance, a significant share of our executive compensation is weighted with long-term incentives. |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| Accretive Health                | Corvel                      | Merge Healthcare             |
|---------------------------------|-----------------------------|------------------------------|
| Advisory Board                  | eHealth                     | Metropolitan Health Networks |
| Allscripts Healthcare Solutions | Ensign Group                | Molina Healthcare            |
| AmSurg                          | Fair Isaac                  | Providence Service Corp      |
| AthenaHealth                    | Hanger Orthopedic           | Quality Systems              |
| Bio-Reference Labs              | HealthStream                | Skilled Healthcare           |
| Capella Healthcare              | IPC The Hospitalist Company | U.S. Physical Therapy        |
| Centene                         | MedAssets                   | Universal American           |
| Computer Programs & Systems | Medidata Solutions          | WebMD Health                 |

| · | Caps on incentive awards equal to two times target; |
|--------|-----------------------------------------------------|

| · | Disclosure of forward-looking performance targets for both short- and long-term incentive awards; |
|--------|---------------------------------------------------------------------------------------------------|

| · | Establishment of a revised peer group to evaluate the executive compensation program; |
|--------|---------------------------------------------------------------------------------------|

| · | Implementation of a recoupment policy; |
|--------|----------------------------------------|

| · | Elimination of Section 280G gross-up payments for all new employment agreements; and |
|--------|--------------------------------------------------------------------------------------|

| · | Adoption of an anti-hedging policy. |
|--------|-------------------------------------|

----

|  Name         | 2013Base Salary | 2012Base Salary(at end of year) | PercentageIncrease | Date of PreviousIncrease |
|--------------------|-----------------|---------------------------------|--------------------|--------------------------|
|               |            |                            |               |                     |
| Ben R. Leedle, Jr. | $712            | $712                            | 0%                 | 03/2008                  |
| Alfred Lumsdaine   | $385            | $350                            | 10%                | 02/2012                  |
| Peter Choueiri (1) | $438            | $409                            | 4%                 | 01/2012                  |
| Michael Farris     | $700            | $700                            | 0%                 | 08/2011                  |
| Glenn Hargreaves   | $258            | $253                            | 2%                 | 07/2012                  |
| Mary Flipse        | $258            | $253                            | 2%                 | 07/2012                  |

| (1) | Mr. Choueiri is paid in Euros.  Estimated salary in dollars is based on the average conversion rate for each year as calculated using the first and last business days of the year. |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| · | Short-Term Cash Incentive Target Percentages |
|--------|----------------------------------------------|

----

| Name               | 2013   | 2012   |
|--------------------|--------|--------|
|               |   |   |
| Ben R. Leedle, Jr. | 70%    | 70%    |
| Alfred Lumsdaine   | 55%    | 50%    |
| Peter Choueiri     | 50%    | 50%    |
| Michael Farris (1) | n/a    | n/a    |
| Glenn Hargreaves   | 45%    | 45%    |
| Mary Flipse        | 45%    | 38%(2) |

| (1) | Not eligible to participate in short-term cash incentive |
|-----|----------------------------------------------------------|

| (2) | Blended rate.  Short-term cash incentive target was 30% |
|-----|--------------------------------------------------------------|

| · | Short-Term Cash Incentive Performance Measures |
|--------|------------------------------------------------|

| Name               | 2013 at Target | 2013 Payout |
|--------------------|----------------|-------------|
|               |           |        |
| Ben R. Leedle, Jr. | $499           | $0          |
| Alfred Lumsdaine   | $208           | $0          |
| Peter Choueiri (1) | $217           | $109        |
| Michael Farris (2) | n/a            | n/a         |
| Glenn Hargreaves   | $115           | $0          |
| Mary Flipse        | $115           | $0          |

| (1) | Mr. Choueiri is paid in Euros. Estimated payout in dollars |
|-----|-----------------------------------------------------------------|

----

| (2) | Not eligible to participate in short-term cash incentive |
|-----|----------------------------------------------------------|

| · | LTI Mix |
|--------|---------|

| Incentive                     | Objective                                                                                          | Approximate Percentage of LTI Award Value |
|-------------------------------|----------------------------------------------------------------------------------------------------|-------------------------------------------|
|                          |                                                                                               | Healthways'  Target Mix              | Healthways'  2013 Awards |
| Stock options                 | Encourage executive retention and promote share price appreciation                                 | 25%                                       | 31% |
| Restricted stock units        | Encourage executive retention, promote share price appreciation, and minimize stockholder dilution | 25%                                       | 19% |
| Performance-based cash awards | Encourage executive retention and align executives with the Company's financial goals              | 50%                                       | 50% |

----

| · | LTI Target Percentages |
|--------|------------------------|

| Name               | 2013   | 2012    |
|--------------------|--------|---------|
|               |   |    |
| Ben R. Leedle, Jr. | 375%   | 375%(1) |
| Alfred Lumsdaine   | 200%   | 180%    |
| Peter Choueiri     | 200%   | 200%(2) |
| Michael Farris (3) | n/a    | n/a     |
| Glenn Hargreaves   | 120%   | 90%(4)  |
| Mary Flipse        | 120%   | 50%(4)  |

|  | (1) | Does not include the Performance Award described on page 39. |
|--|-----|--------------------------------------------------------------|

|  | (2) | During 2012, Mr. Choueiri's LTI target was 200%, which |
|--|-----|--------------------------------------------------------|

|  | (3) | Not eligible to participate in standard LTI program due to |
|--|-----|------------------------------------------------------------|

|  | (4) | Ms. Flipse and Mr. Hargreaves received promotional equity |
|--|-----|-----------------------------------------------------------|

| · | Stock Options and Restricted Stock Units |
|--------|------------------------------------------|

----

|  Name         | StockOptions | ExercisePrice |  RSUs |
|--------------------|--------------|---------------|------------|
|               |         |          |       |
| Ben R. Leedle, Jr. | 117,307      | $12.85        | 39,501     |
| Alfred Lumsdaine   | 33,811       | $12.85        | 11,385     |
| Peter Choueiri     | 37,008       | $12.85        | 12,462     |
| Michael Farris (1) | n/a          | n/a           | n/a        |
| Glenn Hargreaves   | 13,568       | $12.85        | 4,569      |
| Mary Flipse        | 13,568       | $12.85        | 4,569      |

|  | (1) | As previously noted, Mr. Farris currently is not eligible for LTI grants due to a separate three-year incentive award described on page 26. |
|--|-----|---------------------------------------------------------------------------------------------------------------------------------------------|

| · | Vesting |
|--------|---------|

| · | Performance-Based Cash Awards - Domestic |
|--------|------------------------------------------|

----

|          | Portion of Grant to be Measured in Each Year |
|---------------|----------------------------------------------|
| Year of Grant | 2011                                         | 2012 | 2013 | 2014 | 2015 |
|          |                                         |   |   |   |   |
| 2011          | 331/3%                                       | 331/3% | 331/3% |   |   |
| 2012          |                                         | 331/3% | 331/3% | 331/3% |   |
| 2013          |                                         |   | 331/3% | 331/3% | 331/3% |
| RevenueGrowth %(2013 vs. 2012) | 2013, Yr 1 Percentage Earned |      |
|--------------------------------|------------------------------|-----------|
| 0-5%                           | 0%                           |      |
| 5%                             | 25%                          | Threshold |
| 9%                             | 50%                          |      |
| 11%                            | 75%                          |      |
| 13%                            | 100%                         | Target    |
| 22%                            | 200%                         | Maximum   |

| · | Performance-Based Cash Awards - International |
|--------|-----------------------------------------------|

----

| Name               | 2011, Yr 3 Amount Earned | 2012, Yr 2 Amount Earned | 2013, Yr 1 Amount Earned |
|--------------------|--------------------------|--------------------------|--------------------------|
|               |                     |                     |                     |
| Ben R. Leedle, Jr. | $0                       | $0                       | $0                       |
| Alfred Lumsdaine   | $0                       | $0                       | $0                       |
| Peter Choueiri (1) | n/a                      | n/a                      | $0                       |
| Michael Farris (2) | n/a                      | n/a                      | n/a                      |
| Glenn Hargreaves   | $0                       | $0                       | $0                       |
| Mary Flipse        | $0                       | $0                       | $0                       |

|  | (1) | Mr. Choueiri's performance-based cash grants for 2011, 2012, and 2013 had a one-year measurement period. |
|--|-----|----------------------------------------------------------------------------------------------------------|

|  | (2) | Mr. Farris became an employee of the Company in August 2011 and currently is not eligible for the long-term incentive grants due to a separate three-year incentive award described below. |
|--|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| · | Incentive Award for Mr. Farris |
|--------|--------------------------------|

| · | 401(k) Plan |
|--------|-------------|

----

| · | Capital Accumulation Plan ("CAP") |
|--------|-----------------------------------|

----

| Accretive Health             | Bio-Reference Laboratories | IPC The Hospitalist Company |
|------------------------------|----------------------------|-----------------------------|
| Advisory Board               | BioScrip                   | LHC Group                   |
| Air Methods                  | CorVel                     | MedAssets                   |
| Alliance Healthcare Services | Ensign Group               | Omnicell                    |
| Amedisys                     | ExamWorks Group            | Providence Service Corp     |
| AMN Healthcare Services      | Fair Isaac                 | Quality Systems             |
| AmSurg                       | Hanger Orthopedic          | WebMD Health                |

----

| · | Base Salaries |
|--------|---------------|

| Name               | 2014Base Salary | 2013Base Salary(at end of year) | PercentageChange | Date of LastIncrease |
|--------------------|-----------------|---------------------------------|------------------|----------------------|
|               |            |                            |             |                 |
| Ben R. Leedle, Jr. | $712            | $712                            | 0%               | 03/2008              |
| Alfred Lumsdaine   | $385            | $385                            | 0%               | 02/2013              |
| Peter Choueiri (1) | $437            | $437                            | 0%               | 02/2013              |
| Michael Farris     | $700            | $700                            | 0%               | 08/2011              |
| Glenn Hargreaves   | $258            | $258                            | 0%               | 02/2013              |
| Mary Flipse        | $283            | $258                            | 10%              | 02/2013              |

|  | (1) | Mr. Choueiri is paid in Euros.  Estimated salary in dollars for 2013 is based on the average conversion rate for the year as calculated using the first and last business days of the year.  Estimated salary for 2014 is equal to a 0% increase over 2013. |
|--|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| · | Short-term Incentive Award Targets |
|--------|------------------------------------|

|  Name         | Short-termIncentive |
|--------------------|---------------------|
|               |                |
| Ben R. Leedle, Jr. | 70%                 |
| Alfred Lumsdaine   | 55%                 |
| Peter Choueiri     | 50%                 |
| Michael Farris (1) | n/a                 |
| Glenn Hargreaves   | 45%                 |
| Mary Flipse        | 45%                 |

| (1) | Not eligible to participate in short-term incentive program |
|-----|-------------------------------------------------------------|

| · | Short-term Cash Incentive Performance Measure |
|--------|-----------------------------------------------|

----

| · | Long-term Incentive Grants |
|--------|----------------------------|

| · | Long-term Incentive Performance Measure |
|--------|-----------------------------------------|

----

| Cumulative Revenue ($ in millions) For the 21-Month Period Ended 12/31/15 | PercentagePayout |      |
|-------------------------------------------------------------------------------------|------------------|-----------|
| Less than $1,310                                                                    | 0%               |      |
| $1,310                                                                              | 50%              | Threshold |
| $1,331                                                                              | 75%              |      |
| $1,353                                                                              | 100%             | Target    |

| · | Performance-Based Cash Grants from 2013 and 2012 |
|--------|--------------------------------------------------|

| · | Incentive Awards for Mr. Farris |
|--------|---------------------------------|

| · | Anti-Pledging Policy |
|--------|----------------------|

| · | Double-Trigger Vesting Upon a Change In Control |
|--------|-------------------------------------------------|

----

----

| Name and Principal Position                                          | Year           | Salary($)                | Stock Awards($)          | Stock Option Awards($)       | Non-Equity Incentive Plan Compensation($) | Change in Pension Value and Nonqualified Deferred Compensation Earnings | All Other Compensation ($) | Total($)                       |
|----------------------------------------------------------------------|----------------|--------------------------|--------------------------|------------------------------|-------------------------------------------|-------------------------------------------------------------------------|----------------------------|--------------------------------|
|                                                                 |           |                     | (1)                      | (2)                          | (3)                                       | (4)                                                                     | (5)                        |                           |
| Ben R. Leedle, Jr.President and Chief Executive Officer              | 201320122011   | $712,400$712,400$712,400 | $507,588$560,250$667,878 | $828,163$1,113,982$1,905,223 | $--$--$--                                 | $7,983$--$--                                                            | $27,467 (6)$27,082$39,157  | $2,083,601$2,413,714$3,324,658 |
| Alfred LumsdaineExecutive Vice President and Chief Financial Officer | 201320122011   | $378,269$345,193$323,353 | $146,297$146,248$--      | $238,699$146,251$--          | $--$--$--                                 | $878$--$--                                                              | $13,802$12,791$11,947      | $777,945$650,483$335,300       |
| Michael FarrisEVP, Chief Commercial Officer                          | 20132012       | $700,000$700,000         | $--$--                   | $--$--                       | $--$500,000 (7)                           | $--$--                                                                  | $10,810$17,205             | $710,810$1,217,205             |
| Peter Choueiri (8)President, International                           | 20132012       | $434,901$409,453         | $160,137$181,750         | $261,269$102,907             | $108,725 (9)$818,906 (9)                  | $--$--                                                                  | $61,307 (10)$58,142        | $1,026,339$1,571,158           |
| Glenn HargreavesChief Accounting Officer                             | 2013      | $256,538            | $58,712             | $95,787                 | $--                                  | $927                                                               | $9,360                | $421,324                  |
| Mary FlipseSenior Vice President and General Counsel                 | 20132012  | $256,538$230,769    | $58,712$92,900           | $95,787$50,946               | $--$--                                    | $423$--                                                                 | $9,360$46,518              | $420,820$421,133               |

| (1) | Reflects the aggregate grant date fair value of stock awards granted during the respective period calculated in accordance with Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 718. |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2) | Reflects the aggregate grant date fair value of stock option awards granted during the respective period calculated in accordance with FASB ASC Topic 718.  For additional detail regarding the assumptions used in the calculation of these fair value amounts, see Note 13 to our audited financial statements for the fiscal year ended December 31, 2013, included in our Original Form 10-K. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| (3) | For all NEOs except Mr. Farris (see footnote 7 below) and Mr. Choueiri (see footnote 9 below), non-equity incentive plan compensation includes short-term cash incentive awards and performance-based cash awards; however, neither the short-term cash incentive awards nor the performance-based cash awards were earned for 2013, 2012, or 2011 due to the Company not meeting or exceeding established targets.  See Compensation Discussion & Analysis for further detail regarding 2013 targets. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (4) | The amounts in this column represent the above-market portion of the NEOs' earnings in the CAP.  CAP account balances earned daily compound interest of 4.25% per annum during 2013, and such rate was set by the Committee in November 2012.  The amounts shown in the table are equal to the excess of actual interest earned in the CAP by the NEO during 2013 over the interest that would have been earned using 120% of the applicable federal long-term rate with monthly compounding as of November 2012. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (5) | The amounts in this column reflect Company contributions to the 401(k) Plan and the CAP (see below), reimbursement for spousal travel, insurance premiums we paid with respect to life insurance for the benefit of the NEO, and a car allowance and Company contributions to German support funds for Mr. Choueiri (see footnote 10). |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (6) | Includes Company mandatory matching contributions of $14,271 earned by Mr. Leedle during 2013 on his deferrals to the CAP during that time. |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------|

| (7) | Mr. Farris became an employee of the Company in August 2011 in connection with the Company's acquisition of Navvis & Company.  Under the terms of his employment agreement, he is eligible to receive incentive compensation based on achieving annual targets for each of 2012, 2013, and 2014.  If he achieves the annual targets, he is entitled to receive a one-time incentive payment of up to $1.5 million in January 2015.  Mr. Farris fully achieved his annual target for 2012, which was based on the Company entering into a specific new, long-term contract with a health system, but did not achieve his annual target for 2013, which was based on meeting or exceeding the Company's 2013 budget for domestic revenue and EPS. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (8) | Mr. Choueiri is paid in Euros.  Estimated cash compensation in U.S. dollars is based on the average exchange rate for 2013 using the first and last business days of the year. |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (9) | Non-equity incentive plan compensation for Mr. Choueiri includes a short-term incentive award for 2013 and a performance-based cash award for 2012. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------|

----

| (10) | Includes a car allowance as well as Company contributions of $45,120 in German support funds.  In addition to the standard benefit available to our German management team, the Company contributes an additional 5% in lieu of Mr. Choueiri's participation in the CAP. |
|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Name               | Grant Type (1) | GrantDate  | Estimated Future Payouts Under Non-Equity Incentive Plan Awards(2) | All Other Stock Awards: Number of Shares of Stock or Units(#) | All Other Option Awards: Number of Securities Underlying Options(#) | Exercise or Base Price of Option Awards ($/Sh) | Grant Date Fair Value of Stock and Option Awards($) |
|--------------------|----------------|-----------------|--------------------------------------------------------------------|---------------------------------------------------------------|---------------------------------------------------------------------|------------------------------------------------|-----------------------------------------------------|
|               |           | Threshold ($)   | Target($)                                                          | Maximum ($)                                                   |
|               |           |            |                                                               |                                                          |                                                                | (3)                                            | (3)                                                 |   | (4) |
| Ben R. Leedle, Jr. | STC            |            | $--                                                                | $498,680                                                      | $997,360                                                       |                                           |                                                |   |   |
| Ben R. Leedle, Jr. | PC             |            | $333,938                                                           | $1,335,750                                                    | $2,671,500                                                          |                                           |                                                |   |   |
| Ben R. Leedle, Jr. | RSU            | 2/28/13         |                                                               |                                                          |                                                                | 39,501                                         |                                                |   | $507,588 |
| Ben R. Leedle, Jr. | SO             | 2/28/13         |                                                               |                                                          |                                                                |                                           | 117,307                                             | $12.85 | $828,163 |
| Alfred Lumsdaine   | STC            |            | $--                                                                | $208,048                                                      | $416,096                                                            |                                           |                                                |   |   |
| Alfred Lumsdaine   | PC             |            | $96,250                                                            | $385,000                                                      | $770,000                                                            |                                           |                                                |   |   |
| Alfred Lumsdaine   | RSU            | 2/28/13         |                                                               |                                                          |                                                                | 11,385                                         |                                                |   | $146,297 |
| Alfred Lumsdaine   | SO             | 2/28/13         |                                                               |                                                          |                                                                |                                           | 33,811                                              | $12.85 | $238,699 |
| Peter Choueiri     | STC            |            | $--                                                                | $217,451                                                      | $434,902                                                            |                                           |                                                |   |   |
| Peter Choueiri     | IPC            |            | $105,351                                                           | $421,403                                                      | $842,806                                                            |                                           |                                                |   |   |
| Peter Choueiri     | RSU            | 2/28/13         |                                                               |                                                          |                                                                | 12,462                                         |                                                |   | $160,137 |
| Peter Choueiri     | SO             | 2/28/13         |                                                               |                                                          |                                                                |                                           | 37,008                                              | $12.85 | $261,269 |
| Michael Farris     | --             | --              | --                                                                 | --                                                            | --                                                                  | --                                             | --                                                  | -- | -- |

----

| Glenn Hargreaves | STC |    | $--     | $115,442 | $230,884 |   |   |   |    |
|------------------|-----|---------|---------|----------|----------|--------|--------|--------|---------|
| Glenn Hargreaves | PC  |    | $38,625 | $154,500 | $309,000 |   |   |   |    |
| Glenn Hargreaves | RSU | 2/28/13 |    |     |     | 4,569  |   |   | $58,712 |
| Glenn Hargreaves | SO  | 2/28/13 |    |     |     |   | 13,568 | $12.85 | $95,787 |
| Mary Flipse      | STC |    | $--     | $115,442 | $230,884 |   |   |   |    |
| Mary Flipse      | PC  |    | $38,625 | $154,500 | $309,000 |   |   |   |    |
| Mary Flipse      | RSU | 2/28/13 |    |     |     | 4,569  |   |   | $58,712 |
| Mary Flipse      | SO  | 2/28/13 |    |     |     |   | 13,568 | $12.85 | $95,787 |

| (1) | STC: Represents cash awards under the short-term cash incentive program discussed in footnote (5) below. |
|-----|----------------------------------------------------------------------------------------------------------|

| (2) | Non-equity incentive plan awards include short-term cash incentive awards and performance-based cash awards (for all NEOs except Mr. Farris).  These columns set forth the threshold, target, and maximum payouts for performance under these awards.  As described in the section titled "Short-term Cash Incentives" in the "Compensation Discussion and Analysis", bonus payouts range from 0% to 200% of target.  The short-term cash incentive award payment for 2013 performance was 50% of target for Mr. Choueiri (included in the Summary Compensation Table in the column titled "Non-Equity Incentive Plan Compensation") and 0% of target for the other NEOs.  The NEOs did not earn any performance-based cash awards in 2013. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (3) | Awards were granted under the 2007 Plan. |
|-----|------------------------------------------|

| (4) | These amounts represent the aggregate grant date fair value of these awards calculated in accordance with FASB ASC Topic 718. These amounts are reflected in the Summary Compensation Table in the "Stock Awards" and "Stock Option Awards" columns. |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| (5) | Under the 2013 short-term cash incentive program, Mr. Leedle was eligible to receive an award up to 70% of his base salary, Mr. Lumsdaine was eligible to receive an award up to 55% of his base salary, Mr. Choueiri was eligible to receive an award up to 50% of his base salary, and Mr. Hargreaves and Ms. Flipse were eligible to receive an award up to 45% of their base salaries.  For 2013, these short-term cash incentive awards were based upon a comparison of our actual EBITDA to our targeted EBITDA of $85.5 million, as such targeted EBITDA was set by the Committee at the beginning of the fiscal year. In the case of Mr. Choueiri, 50% of his short-term incentive award was based on exceeding the total Company EBITDA target of $85.5 million, while the remaining 50% of his award was based on exceeding an EBITDA target for the international business.  Had our performance exceeded our targeted EBITDA, awards to NEOs could have exceeded the percentages set forth above, with the maximum award amounts for the NEOs capped at 200% of their targeted award amount.  Because total Company EBITDA for 2013 did not exceed our goal of $85.5 million, the NEOs did not earn any bonuses for 2013, except for Mr. Choueiri, who earned 50% of his short-term incentive award based on exceeding the EBITDA target for the international business. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (6) | As more fully explained in the "Compensation Discussion and Analysis" section of this Form 10-K/A, the performance-based cash awards were cash-based grants with three forward-looking one-year performance periods.  Each one-year period provides the recipient with the opportunity to earn up to one-third of the total amount granted for that plan year, provided that performance metrics pre-approved by the Committee are achieved.  If performance metrics are not achieved in a given one-year performance period, the portion of the award attributable to that performance period is forfeited and cannot be realized in a later performance period.  If the Company exceeds its performance metrics, the NEOs could receive awards in excess of such amounts, up to two times their target.  For the 2013 grant, funding began upon achieving the low end of target performance metrics until 100% funding was achieved.  Upon achieving the high end of target performance metrics, additional funding would occur.  The amounts shown in the "Target" column above represent the aggregate amount that could be earned during the three one-year performance periods (2013, 2014, and 2015).  No amounts were earned by the NEOs during 2013 and thus are not included in the Summary Compensation Table. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (7) | Non-equity incentive plan compensation for Mr. Choueiri includes performance-based cash awards.  Mr. Choueiri's performance-based cash award is described more fully on page 25.  Mr. Choueiri's performance-based cash award for 2013 had a one-year measurement period and was based on the achievement of revenue growth targets for the international business.  Based on international revenue growth for 2013, Mr. Choueiri did not earn a performance-based cash award for 2013. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|          | STOCK OPTION AWARDS                                             |
|--------------------|-----------------------------------------------------------------|
| Name               | Option Grant Date                                               | Number of Securities Underlying Unexercised Options(#)Exercisable | Number of Securities Underlying Unexercised Options(#)Unexercisable | Option Exercise Price($) | Option Expiration Date |
| Ben R. Leedle, Jr. | 8/24/0410/8/072/12/092/24/102/28/1111/3/112/21/122/21/122/28/13 | 300,00042,721108,42477,50942,218109,500--37,500-- | ------25,837 (1)42,218 (1)255,500 (2)135,000 (2)112,500 (1)117,307 (1) | $26.33  55.0111.57 15.4413.979.969.967.4712.85 | 8/24/1410/8/142/12/192/24/202/28/2111/3/21 2/21/222/21/222/28/23 |
| Alfred Lumsdaine   | 8/24/042/12/092/24/1012/2/102/21/122/28/13                      | 10,00021,0129,82522,5008,925-- | ----3,275 (1)52,500 (3) 26,776 (1)33,811 (1) |  $26.3311.5715.449.967.4712.85 | 8/24/142/12/192/24/2012/2/202/21/222/28/23 |
| Michael Farris     | --                                                              | -- | -- | -- | -- |
| Peter Choueiri     | 6/01/111/18/122/28/13                                           | 25,0006,250-- | 25,000 (1)18,750 (1)37,008 (1) | $15.837.2712.85 | 6/1/211/18/222/28/23 |
| Glenn Hargreaves   | 2/12/092/24/1012/2/102/21/127/19/122/28/13                      | 6,6212,44411,2503,0891,250-- | --815 (1)26,250 (3)9,269 (1)3,750 (1)13,568(1) | $11.5715.449.967.479.2912.85 | 2/12/192/24/2012/2/202/21/227/19/222/28/23 |
| Mary Flipse        | 7/19/122/28/13                                                  | 2,500-- | 7,500 (1) 13,568 (1) |  $9.2912.85 | 7/19/222/28/23 |

| (1) | Award vests 25% per year on each of the first four anniversaries of the grant date. |
|-----|-------------------------------------------------------------------------------------|

| (2) | Performance Award granted to Mr. Leedle as described more fully below.  Award vests 30% on the second anniversary of the grant date, 30% on the fourth anniversary of the grant date, and 40% on the sixth anniversary of the grant date. |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (3) | Award vests 30% on the second anniversary of the grant date, 30% on the fourth anniversary of the grant date, and 40% on the sixth anniversary of the grant date. |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|               | STOCK AWARDS                        |
|--------------------|-------------------------------------|
| Name               | Stock Award Grant Date              | Number of Shares or Units of Stock That Have Not Vested(#) | Market Value of Shares or Units of Stock That Have Not Vested($) |
|               |                                |   | (5) |
| Ben R. Leedle, Jr. | 2/24/102/28/112/21/122/28/13        | 3,448 (4)23,904 (4) 56,250 (4)39,501 (4) | $52,927366,926863,438606,340 |
| Alfred Lumsdaine   | 2/24/1012/2/102/21/122/28/13        | 437 (4)25,000 (6) 14,684 (4)11,385 (4) | $6,708383,750225,399174,760 |
| Michael Farris     | --                                  | -- | -- |
| Peter Choueiri     | 6/1/111/18/122/28/13                | 12,500 (4)18,750 (4)12,462 (4) | $191,875287,813191,292 |
| Glenn Hargreaves   | 2/24/1012/2/102/21/127/19/122/28/13 | 109 (4)12,500 (6)5,083 (4)3,750 (4)4,569 (4) | $1,673191,87578,02457,56370,134 |
| Mary Flipse        | 7/19/122/28/13                      | 7,500 (4)4,569 (4) | $115,12570,134 |

----

|  | (4) | Award vests 25% per year on each of the first four anniversaries of the grant date. |
|--|-----|-------------------------------------------------------------------------------------|

|  | (5) | Market value was calculated by multiplying the number of RSUs in the previous column that have not vested as of December 31, 2013 times the closing stock price on December 31, 2013. |
|--|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (6) | Award vests on the sixth anniversary of the date of grant. |
|--|-----|------------------------------------------------------------|

|               | Option Awards                         | Stock Awards                 |
|--------------------|---------------------------------------|------------------------------|
|  Name         | Number ofSharesAcquiredon Exercise(#) | Value Realizedon Exercise($) | Number ofSharesAcquiredon Vesting(#) | Value Realizedon Vesting($) |
|               |                                  |                         |   |   |
| Ben R. Leedle, Jr. | 300,000                               | $352,926                     | 47,580 (1) | $552,477 |
| Alfred Lumsdaine   | 9,750                                 | 11,310                       | 7,946 (2) | 89,084 |
| Michael Farris     | --                                    | --                           | -- | -- |
| Peter Choueiri     | --                                    | --                           | 12,500 | 155,813 |
| Glenn Hargreaves   | --                                    | --                           | 3,877 | 50,327 |
| Mary Flipse        | --                                    | --                           | 2,500 | 41,725 |

| (1) | All of the cash proceeds from the exercise of these options were used to pay the aggregate exercise price of the options reported in this table as well as the related withholding tax expenses. The 6,016 shares remaining after the exercise of these options were retained by Mr. Leedle. |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2) | All of the cash proceeds from the exercise of these options were used to pay the aggregate exercise price of the options reported in this table as well as the related withholding tax expenses. The 325 shares remaining after the exercise of these options were retained by Mr. Lumsdaine. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| Name               | Executive Contributions in Last Fiscal Year($) | Registrant Contributions in Last Fiscal Year($) | Aggregate Earnings in Last Fiscal Year ($) | AggregateWithdrawals/ Distributions in Last Fiscal Year($) | Aggregate Balanceat LastFiscal Year-End ($) |
|--------------------|------------------------------------------------|-------------------------------------------------|--------------------------------------------|------------------------------------------------------------|---------------------------------------------|
|               | (1)                                            | (2)                                             | (3)                                        |                                                       |                                        |
| Ben R. Leedle, Jr. | $71,240                                        | $14,271                                         | $23,896                                    | $205,206                                                   | $627,490 (4)                                |
| Alfred Lumsdaine   | $7,565                                         | $3,846                                          | $2,634                                     | $51,023                                                    | $71,516 (5)                                 |
| Michael Farris (6) | $--                                            | $--                                             | $--                                        | $--                                                        | $--                                         |
| Peter Choueiri (6) | $--                                            | $--                                             | $--                                        | $--                                                        | $--                                         |
| Glenn Hargreaves   | $20,232                                        | $631                                            | $2,772                                     | $55,163                                                    | $77,128                                     |
| Mary Flipse        | $25,654                                        | $800                                            | $1,260                                     | $--                                                        | $44,192 (5)                                 |

| (1) | These amounts are included in the Summary Compensation Table in the "Salary" column for 2013. |
|-----|-----------------------------------------------------------------------------------------------|

| (2) | These amounts were contributed to the CAP in 2014 but are attributable to 2013.  Such amounts are included in the Summary Compensation Table in the "All Other Compensation" column for 2013.  The Company's contributions to the CAP vest equally over four years from the effective date of the contribution. |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (3) | Amounts represent the NEO's earnings during the period on balances in the CAP.  The above-market portion of these earnings during 2013 is included in the Summary Compensation Table in the "Nonqualified Deferred Compensation Earnings" column. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (4) | Excluding $93,494 reported in the Summary Compensation Table for 2013, the majority of this amount includes amounts previously reported in summary compensation tables contained in the Company's prior proxy statements as compensation to Mr. Leedle. |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (5) | Includes amounts previously reported in summary compensation tables contained in the Company's prior proxy statements as compensation to Mr. Lumsdaine ($18,817); and Ms. Flipse ($16,266). |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (6) | As noted above, Messrs. Farris and Choueiri are not eligible to participate in the CAP. |
|-----|-----------------------------------------------------------------------------------------|

----

| 1) | Involuntary without Cause – the Company may terminate each NEO's employment without cause at any time (and, in the case of Messrs. Farris and Choueiri, upon the recommendation of the Company's CEO) by delivery of a written notice of termination to the executive. |
|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2) | Voluntary for Good Reason – the NEO may resign by delivery of a written notice of resignation to the Company within 60 days of the occurrence of any of the following events: |
|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| a. | for NEOs other than Mr. Choueiri, a material reduction in the NEO's base salary unless such reduction is part of an across the board reduction affecting all Company executives with a comparable title, or, in the case of Mr. Farris, if such reduction occurs pursuant to the terms of his employment agreement; |
|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| b. | a requirement by the Company to relocate the NEO to a location that is more than 25 miles from the location of the NEO's current office; |
|----|------------------------------------------------------------------------------------------------------------------------------------------|

----

| c. | in connection with a Change in Control (as defined below), the failure by the successor or the Company's Board to honor the NEO's employment agreement or offer such NEO an employment agreement containing substantially similar or otherwise satisfactory terms; |
|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| d. | a material reduction in the NEO's title, or a material and adverse change in NEO's status and responsibilities, or the assignment to executive of duties or responsibilities which are materially inconsistent with the NEO's status and responsibilities; |
|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| e. | for Mr. Choueiri, in connection with a Change of Control, his reporting relationship is changed from the CEO of the Company; or |
|----|---------------------------------------------------------------------------------------------------------------------------------|

| f. | for Mr. Choueiri, a reason for cause as per German law. |
|----|---------------------------------------------------------|

| 3) | Involuntary for Cause – the Company may, at any time, terminate the employment of a NEO, other than Mr. Choueiri, by delivery of a written notice of termination to the executive specifying the event(s) relied upon for such termination upon the occurrence of any of the following: |
|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| a. | continued failure of the executive to substantially perform his or her duties after written notice and failure to cure within 60 days; |
|----|----------------------------------------------------------------------------------------------------------------------------------------|

| b. | conviction of a felony or engaging in misconduct which is materially injurious to the Company, monetarily or to its reputation or otherwise, or which would damage the executive's ability to effectively perform his or her duties; |
|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| c. | theft or dishonesty by the executive; |
|----|---------------------------------------|

| d. | intoxication while on duty; or |
|----|--------------------------------|

| e. | willful violation of Company policies and procedures after written notice and failure to cure within 30 days. |
|----|---------------------------------------------------------------------------------------------------------------|

| 4) | Voluntary without Good Reason – each NEO may terminate his or her employment at any time by delivery of a written notice of resignation to the Company no less than 60 days and no more than 90 days prior to the effective date of such executive's resignation, except that Mr. Choueiri's notice period is six months to the end of a calendar month. |
|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 5) | Change in Control - "Change in Control" is defined in each of the NEOs' employment agreements as any of the following events: |
|----|-------------------------------------------------------------------------------------------------------------------------------|

| (i) | when any person or entity, including a "group" as defined in Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, other than the Company or a wholly owned subsidiary thereof or any employee benefit plan of the Company or any of its subsidiaries, becomes the beneficial owner of the Company's securities having 35% or more of the combined voting power of the then outstanding securities of the Company that may be cast for the election of directors of the Company (other than as a result of an issuance of securities initiated by the Company in the ordinary course of business), |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (ii) | as the result of, or in connection with, any cash tender or exchange offer, merger or other business combination, sales of assets or contested election, or any combination of the foregoing transactions, less than a majority of the combined voting power of the then outstanding securities of the Company or any successor corporation or entity entitled to vote generally in the election of the directors of the Company or such other corporation or entity after such transaction is held in the aggregate by the holders of the Company's securities entitled to vote generally in the election of the directors of the Company immediately prior to such transaction, or |
|------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| (iii) | during any period of two consecutive years, individuals who at the beginning of any such period constitute the Board cease for any reason to constitute at least a majority thereof, unless the election, or the nomination for election by the Company's stockholders, of each director of the Company first elected during such period was approved by a vote of at least two-thirds of the directors of the Company then still in office who were directors of the Company at the beginning of any such period. |
|-------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 6) | Involuntary without Cause or Voluntary for Good Reason within 12 Months of a Change in Control – a NEO may terminate his or her employment within 12 months of a Change in Control for good reason or the Company may terminate such NEO's employment within 12 months of a Change in Control without cause. |
|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 7) | Disability – each NEO's employment, other than Mr. Choueiri, may be terminated by either the NEO or the Company upon written notice to the other party when: |
|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| a. | the NEO suffers a physical or mental disability entitling the NEO to long-term disability benefits under the Company's long-term disability plan, if any, or |
|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------|

| b. | in the absence of a Company long-term disability plan, the NEO is unable, as determined by the Board (or any designated Committee of the Board), to perform the essential functions of the NEO's regular duties and responsibilities, with or without reasonable accommodation, due to a medically determinable physical or mental illness which has lasted (or can reasonably be expected to last) for a period of six consecutive months. |
|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 8) | Death – each NEO's employment terminates upon his or her death. |
|----|-----------------------------------------------------------------------|

| 9) | Retirement – under the CAP and the 2007 Plan, "normal retirement" occurs upon a "separation from service" (in the case of the CAP) or the retirement from active service (in the case of the 2007 Plan) of the NEO on or after the date upon which the NEO reaches the age of 65. Under the CAP and the 2007 Plan, "early retirement" occurs where (i) the sum of the NEO's age plus years of employment at the Company as of the proposed retirement date is equal to or greater than 70, (ii) the NEO has given written notice to the Company at least one year prior to the proposed early retirement date of his or her intent to retire and (iii) the CEO has approved in writing such early retirement request prior to the proposed early retirement date, provided that in the event the CEO does not approve the request for early retirement or the CEO is the NEO giving notice of his intent to retire, then in both cases, the Compensation Committee (in the case of the CAP) or the Board (in the case of the 2007 Plan) shall make the determination of whether to approve or disapprove such request. Under the CAP, a "separation from service" means any one of the following events: (i) the NEO is discharged by the Company, (ii) the NEO voluntarily terminates employment (including a normal or early retirement) with the Company, (iii) the NEO terminates employment due to disability, or (iv) the NEO dies while employed by the Company. |
|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|                            | Involuntary Without                                                                                                                                                                                                                                     |   |                                                                                                                |   | Voluntary                                                                                                                                         |      |                                                                                                                |      |
|---------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|---------------------------------------------------------------------------------------------------------------------|--------|---------------------------------------------------------------------------------------------------------------------------------------------------|-----------|---------------------------------------------------------------------------------------------------------------------|-----------|
|                            | Cause or Voluntary                                                                                                                                                                                                                                      |   | Involuntary                                                                                                         |   | Without Good                                                                                                                                      |      | Early                                                                                                               |      |
|                            | For Good Reason                                                                                                                                                                                                                                         |   | For Cause                                                                                                           |   | Reason                                                                                                                                            |      | Retirement                                                                                                          |      |
|                            | on 12/31/13                                                                                                                                                                                                                                             |   | on 12/31/13                                                                                                         |   | on 12/31/13                                                                                                                                       |      | on 12/31/13                                                                                                         |      |
|                            |                                                                                                                                                                                                                                                    |   |                                                                                                                |   |                                                                                                                                              |      |                                                                                                                |      |
|  Cash Severance            |  $                      1,424,800                                                                                                                                                           | (1)    |  $               -                                                     |   |  $          27,400                                                                                                  |  (2) |  $               -                                                     |      |
|  Group Medical Benefits    |                                33,978                                                        | (3)    |                    - |   |                     653                       |  (2) |                    - |      |
|  Annual Incentive Award    |                                          - | (4)    |                    - |   |                         - |      |                    - |      |
|  Performance Cash          |                                          - | (5)    |                    - |   |                         - |      |                    - |  (5) |
|  Stock Options             |                           1,238,028                                                                                   | (6)    |                    - |   |                         - |      |                    - | (11)      |
|  Restricted Stock Units    |                            1,889,631                                                                             | (6)    |                    - |   |                         - |      |                    - | (11)      |
|  Performance Award         |                           2,104,795                                                                                   | (6)    |   -                                                                                                       |   |   -                                                                                                                                     |      |                    - | (11)      |
|  Capital Accumulation Plan |                               613,524                                                             | (7)    |                    - |   |                         - |      |        613,524                                                                   | (7)       |
|  Additional Severance      |                              356,200                                                                   | (8)    |       356,200                                                                         | (8)    |                         - |      |                    - |      |
|  Total                     |  $                     7,660,956                                                                                                                                                            |   |  $  356,200                                                                                               |   |  $          28,053                                                                                                  |      |  $   613,524                                                                                         |      |

----

|                            |                                                                                                                                                          |       | Involuntary Without                                                                                                                                                                                                             |       |                                                                                                                |          |                                                                                                                            |      |
|---------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|---------------------------------------------------------------------------------------------------------------------|---------------|---------------------------------------------------------------------------------------------------------------------------------|-----------|
|                            |                                                                                                                                                          |       |  Cause or Voluntary For                                                                                                                                                                                                    |       |                                                                                                                |          |                                                                                                                            |      |
|                            |                                                                                                                                                          |       | Good Reason                                                                                                                                                                                                                     |       |                                                                                                                |          |                                                                                                                            |      |
|                            |                                                                                                                                                          |       | Within 12 Months of a                                                                                                                                                                                                           |       |                                                                                                                |          |                                                                                                                            |      |
|                            | Change in Control                                                                                                                                             |       | Change in Control                                                                                                                                                                                                               |       | Disability                                                                                                          |          | Death                                                                                                                           |      |
|                            | on 12/31/13                                                                                                                                                   |       | on 12/31/13                                                                                                                                                                                                                     |       | on 12/31/13                                                                                                         |          | on 12/31/13                                                                                                                     |      |
|                            |                                                                                                                                                          |       |                                                                                                                                                                                                                            |       |                                                                                                                |          |                                                                                                                            |      |
|  Cash Severance            |  $                       -                                                                   |       |  $                   1,424,800                                                                                                                                           |  (1)  |  $ 1,424,800                                                                                                   |  (9) (1) |  $                  -                                                         |      |
|  Group Medical Benefits    |                           - |       |                             33,978                                                  |  (3)  |          33,978                                                        |  (3)     |                      - |      |
|  Annual Incentive Award    |                           - |       |                                      - |  (4)  |                    - | (4)           |                      - | (4)       |
|  Performance Cash          |              1,223,112                                                                       |  (10) |                         1,223,112                                                                       |  (10) |                    - |  (5)     |                      - |  (5) |
|  Stock Options             |            1,238,028                                                                                   | (6)        |                       1,238,028                                                                                   | (6)        |     1,238,028                                                                                   | (6)           |       1,238,028                                                                                   | (6)       |
|  Restricted Stock Units    |             1,889,631                                                                             | (6)        |                        1,889,631                                                                             | (6)        |      1,889,631                                                                             | (6)           |        1,889,631                                                                             | (6)       |
|  Performance Award         |             2,104,795                                                                             | (6)        |                        2,104,795                                                                             | (6)        |      2,104,795                                                                             | (6)           |        2,104,795                                                                             | (6)       |
|  Capital Accumulation Plan |                613,524                                                             | (7)        |                           613,524                                                             | (7)        |         613,524                                                             | (7)           |           613,524                                                             | (7)       |
|  Additional Severance      |                           - |       |                          356,200                                                                   | (8)        |        356,200                                                                   | (8)           |                      - |      |
|  Total                     |  $        7,069,090                                                                                                                  |       |  $                  8,884,068                                                                                                                                                 |       |  $ 7,660,956                                                                                                   |          |  $   5,845,978                                                                                                   |      |

|  | (1) | Represents 24 months of NEO's base salary to be paid at regular payroll dates following the NEO's termination.  Following a change in control, the payments would be paid in a lump sum no later than 60 days following the date of termination. |
|--|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (2) | For termination by the NEO without good reason, the NEO is entitled to base salary and benefits through the next payroll date following termination. |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (3) | Represents the Company's portion of premiums for group medical benefits to be paid for 24 months following the NEO's termination. |
|--|-----|-----------------------------------------------------------------------------------------------------------------------------------|

|  | (4) | Following a termination (a) without cause, (b) for good reason, (c) without cause or for good reason within 12 months of a change in control, or (d) because of disability or death, the NEO is entitled to receive a pro-rata portion of any bonus to which the NEO is otherwise entitled as of the date of termination.  Based on Company performance for 2013, the NEO was not entitled to a bonus as of December 31, 2013.  No additional incentive amounts would be paid during the severance period. |
|--|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (5) | Following a termination (a) without cause, (b) for good reason, (c) in connection with a normal or early retirement, or (d) because of disability or death, the NEO is entitled to receive any amounts previously earned by the NEO under the Company's performance-based cash incentive plan, which would include the earned amount for year one of the 2013 award, years one and two of the 2012 award, and years one through three of the 2011 award.  Based on Company performance, no amounts were earned by the NEO for these performance periods.  With the exception of the accelerated vesting due to the termination events described in the table, the performance-based cash award vests on the third anniversary of the grant date. |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (6) | Following a change in control or a termination (a) without cause, (b) for good reason, (c) without cause or for good reason within 12 months of a change in control, or (d) because of disability or death, unvested equity awards will vest and remain exercisable in accordance with the terms of the applicable award agreements.  The values in the table are based upon the difference between the Company's closing stock price on December 31, 2013 of $15.35 per share and the exercise price of the awards, including only those awards whose exercise price was below the market price on December 31, 2013.  RSUs have an exercise price of zero. |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (7) | Following a change in control or a termination (a) without cause, (b) for good reason, (c) without cause or for good reason within 12 months of a change in control, (d) because of disability or death, or (e) in connection with a normal or early retirement, all amounts contributed by the Company to the CAP for the benefit of the NEO will vest.  The amount in the table above reflects the NEO's aggregate CAP balance as of December 31, 2013, of which $585,709 was vested, and excludes Company contributions attributable to fiscal 2013, as they were not made until fiscal 2014.  The remaining portion was unvested at December 31, 2013 but would vest upon termination of the NEO for the reasons listed in clauses (a) through (e) above. |
|--|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|  | (8) | Assumes execution of full release of claims in favor of the Company.  Represents six months of the NEO's base salary to be paid at regular payroll dates following the NEO's termination. |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (9) | Although not reflected in this table, this amount would be reduced by any disability insurance payments paid by the insurance company to the NEO as a result of the NEO's disability.  In the event of disability, the NEO would receive $12,000 per each month of disability from the insurance company until reaching age 67. |
|--|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (10) | Following a change in control, all amounts granted under the Company's performance-based cash incentive plan would vest (to the extent not previously forfeited). |
|--|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (11) | Following a termination in connection with normal or early retirement, unvested equity awards will not be forfeited but will continue vesting in accordance with the applicable award agreements. |
|--|------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|                            | Involuntary Without                                                                                                                                                                                                                                                       |   |                                                                                                                      |   | Voluntary                                                                                                                                               |      |
|---------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|---------------------------------------------------------------------------------------------------------------------------|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------|-----------|
|                            | Cause or Voluntary                                                                                                                                                                                                                                                        |   | Involuntary                                                                                                               |   | Without Good                                                                                                                                            |      |
|                            | For Good Reason                                                                                                                                                                                                                                                           |   | For Cause                                                                                                                 |   | Reason                                                                                                                                                  |      |
|                            | on 12/31/13                                                                                                                                                                                                                                                               |   | on 12/31/13                                                                                                               |   | on 12/31/13                                                                                                                                             |      |
|                            |                                                                                                                                                                                                                                                                      |   |                                                                                                                      |   |                                                                                                                                                    |      |
|  Cash Severance            |  $                            577,500                                                                                                                                                          | (1)    |  $                -                                                          |   |  $            14,808                                                                                                 |  (2) |
|  Group Medical Benefits    |                                     25,311                                            | (3)    |                     - |   |                      649                       |  (2) |
|  Annual Incentive Award    |                                             - | (4)    |                     - |   |                          - |      |
|  Performance Cash          |                                             - | (5)    |                     - |   |                          - |      |
|  Stock Options             |                                 578,497                                                                   | (6)    |                     - |   |                          - |      |
|  Restricted Stock Units    |                                  790,617                                                             | (6)    |                     - |   |                          - |      |
|  Capital Accumulation Plan |                                   67,706                                                        | (7)    |                     - |   |                          - |      |
|  Additional Severance      |                                  192,500                                                             | (8)    |          192,500                                                             | (8)    |                          - |      |
|  Total                     |  $                          2,232,131                                                                                                                                                               |   |  $     192,500                                                                                        |   |  $            15,457                                                                                                 |      |

----

|                            |                                                                                                                                                                      |       | Involuntary Without                                                                                                                                                                                                             |       |                                                                                                                |          |                                                                                                                |   |
|---------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|---------------------------------------------------------------------------------------------------------------------|---------------|---------------------------------------------------------------------------------------------------------------------|--------|
|                            |                                                                                                                                                                      |       |  Cause or Voluntary For                                                                                                                                                                                                    |       |                                                                                                                |          |                                                                                                                |   |
|                            |                                                                                                                                                                      |       | Good Reason                                                                                                                                                                                                                     |       |                                                                                                                |          |                                                                                                                |   |
|                            |                                                                                                                                                                      |       | Within 12 Months of a                                                                                                                                                                                                           |       |                                                                                                                |          |                                                                                                                |   |
|                            | Change in Control                                                                                                                                                         |       | Change in Control                                                                                                                                                                                                               |       | Disability                                                                                                          |          | Death                                                                                                               |   |
|                            | on 12/31/13                                                                                                                                                               |       | on 12/31/13                                                                                                                                                                                                                     |       | on 12/31/13                                                                                                         |          | on 12/31/13                                                                                                         |   |
|                            |                                                                                                                                                                      |       |                                                                                                                                                                                                                            |       |                                                                                                                |          |                                                                                                                |   |
|  Cash Severance            |  $                    -                                               |       |  $                   577,500                                                                                                          | (1)        |  $      577,500                                                                                 |  (9) (1) |  $                -                                                    |   |
|  Group Medical Benefits    |                             - |       |                              25,311                                            | (3)        |           33,749                                                  | (3)           |                    - |   |
|  Annual Incentive Award    |                             - |       |                                      - | (4)        |                    - | (4)           |                    - | (4)    |
|  Performance Cash          |                  321,667                                                             |  (10) |                           321,667                                                             |  (10) |                    - | (5)           |                    - | (5)    |
|  Stock Options             |                  578,497                                                             | (6)        |                           578,497                                                             | (6)        |         578,497                                                             | (6)           |         578,497                                                             | (6)    |
|  Restricted Stock Units    |                  790,617                                                             | (6)        |                           790,617                                                             | (6)        |          790,617                                                       | (6)           |          790,617                                                       | (6)    |
|  Capital Accumulation Plan |                    67,706                                                  | (7)        |                             67,706                                                  | (7)        |           67,706                                                  | (7)           |           67,706                                                  | (7)    |
|  Additional Severance      |                             - |       |                           192,500                                                             | (8)        |         192,500                                                             | (8)           |                    - |   |
|  Total                     | $       1,758,487                                                                                                                           |       |  $                 2,553,798                                                                                                               |       |  $ 2,240,569                                                                                                   |          |  $ 1,436,820                                                                                                   |   |

|  | (1) | Represents 18 months of NEO's base salary to be paid at regular payroll dates following the NEO's termination.  Following a change in control, the payments would be paid in a lump sum no later than 60 days following the date of termination. |
|--|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (2) | For termination by the NEO without good reason, the NEO is entitled to base salary and benefits through the next payroll date following termination. |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (3) | Represents the Company's portion of premiums for group medical benefits to be paid for 18 months following the NEO's termination.  For termination due to disability, represents the Company's portion of premiums for group medical benefits to be paid for 24 months following the NEO's termination. |
|--|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (4) | Following a termination (a) without cause, (b) for good reason, (c) without cause or for good reason within 12 months of a change in control, or (d) because of disability or death, the NEO is entitled to receive a pro-rata portion of any bonus to which the NEO is otherwise entitled as of the date of termination.  Based on Company performance for 2013, the NEO was not entitled to a bonus as of December 31, 2013.  No additional incentive amounts would be paid during the severance period. |
|--|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (5) | Following a termination (a) without cause, (b) for good reason, (c) in connection with a normal or early retirement, or (d) because of disability or death, the NEO is entitled to receive any amounts previously earned by the NEO under the Company's performance-based cash incentive plan, which would include the earned amount for year one of the 2013 award, years one and two of the 2012 award, and years one through three of the 2011 award.  Based on Company performance, no amounts were earned by the NEO for these performance periods.  With the exception of the accelerated vesting due to the termination events described in the table, the performance-based cash award vests on the third anniversary of the grant date. |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (6) | Following a change in control or a termination (a) without cause, (b) for good reason, (c) without cause or for good reason within 12 months of a change in control, or (d) because of disability or death, unvested equity awards will vest and remain exercisable in accordance with the terms of the applicable award agreements.  The values in the table are based upon the difference between the Company's closing stock price on December 31, 2013 of $15.35 per share and the exercise price of the awards, including only those awards whose exercise price was below the market price on December 31, 2013.  RSUs have an exercise price of zero. |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (7) | Following a change in control or a termination (a) without cause, (b) for good reason, (c) without cause or for good reason within 12 months of a change in control, (d) because of disability or death, or (e) in connection with a normal or early retirement, all amounts contributed by the Company to the CAP for the benefit of the NEO will vest.  The amount in the table above reflects the NEO's aggregate CAP balance as of December 31, 2013, of which $58,310 was vested, and excludes Company contributions attributable to 2013, as they were not made until fiscal 2014.  The remaining portion was unvested at December 31, 2013, but would vest upon termination of the NEO for the reasons listed in clauses (a) through (e) above. |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|  | (8) | Assumes execution of full release of claims in favor of the Company.  Represents six months of the NEO's base salary to be paid at regular payroll dates following the NEO's termination. |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (9) | Although not reflected in this table, this amount would be reduced by any disability insurance payments paid by the insurance company to the NEO as a result of the NEO's disability.  In the event of disability, the NEO would receive $12,000 per each month of disability from the insurance company until reaching age 67. |
|--|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (10) | Following a change in control, all amounts granted under the Company's performance-based cash incentive plan would vest (to the extent not previously forfeited). |
|--|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|                              |                                                                                                                                                                            |      | Voluntary                                                                                                                                   |   | Involuntary Without                                                                                                                                                                                                |      |
|-----------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------|---------------------------------------------------------------------------------------------------------------------------------------------|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------|
|                              | Involuntary                                                                                                                                                                     |      | Without Good                                                                                                                                |   | Cause or Voluntary                                                                                                                                                                                                 |      |
|                              | Without Cause                                                                                                                                                                   |      | Reason or                                                                                                                                   |   | for Good Reason                                                                                                                                                                                                    |      |
|                              | or Voluntary                                                                                                                                                                    |      | Involuntary                                                                                                                                 |   | Within 12 Months of a                                                                                                                                                                                              |      |
|                              | for Good Reason                                                                                                                                                                 |      | For Cause                                                                                                                                   |   | Change in Control                                                                                                                                                                                                  |      |
|                              | on 12/31/13                                                                                                                                                                     |      | on 12/31/13                                                                                                                                 |   | on 12/31/13                                                                                                                                                                                                        |      |
|                              |                                                                                                                                                                            |      |                                                                                                                                        |   |                                                                                                                                                                                                               |      |
|  Cash Severance              |  $            656,561                                                                                                                        |  (1) |  $                   -                                                               |   |  $                        656,561                                                                                                                 |  (1) |
|  Medical Benefits            |                      11,121                                            |  (2) |                        - |   |                                   11,121 |  (2) |
|  Annual Incentive Award      |                 108,725                                                                         |  (3) |                        - |   |                             108,725                                    |  (3) |
|  Car Allowance               |                   24,281                                                              |  (4) |                        - |   |                                24,281                   |  (4) |
|  Performance Cash            |                              - |  (5) |                        - |   |                              561,163                              |  (9) |
|  Stock Options               |                244,020                                                                               |  (6) |                        - |   |                            244,020                                          |  (6) |
|  Restricted Stock Units      |                670,980                                                                               |  (6) |                        - |   |                            670,980                                          |  (6) |
|  Long-Term Performance Award |                              - |  (7) |                        - |   |                               40,338                         |  (9) |
|  Non-compete Consideration   |                 516,990                                                                         |  (8) |             516,990                                                             | (8)    |                             516,990                                    |  (8) |
|  Total                       |  $       2,232,678                                                                                                                                     |      |  $        516,990                                                                                                  |   |  $                     2,834,179                                                                                                                       |      |

----

|                              |                                                                                                                                                                                                                |      |                                                                                                                                                    |           |                                                                                                                                        |      |
|-----------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------|----------------|---------------------------------------------------------------------------------------------------------------------------------------------|-----------|
|                              | Change in Control                                                                                                                                                                                                   |      | Disability                                                                                                                                              |           | Death                                                                                                                                       |      |
|                              | on 12/31/13                                                                                                                                                                                                         |      | on 12/31/13                                                                                                                                             |           | on 12/31/13                                                                                                                                 |      |
|                              |                                                                                                                                                                                                                |      |                                                                                                                                                    |           |                                                                                                                                        |      |
|  Cash Severance              |  $                              -                                                                                                   |      |  $         656,561                                                                                                        |  (1) (10) |  $                  -                                                                     |      |
|  Medical Benefits            |                                  -             |      |                  11,121                                            | (2)            |                      -             |      |
|  Annual Incentive Award      |                                  -             |      |                          - |           |            108,725                                                                   | (3)       |
|  Car Allowance               |                                  -             |      |                          - |           |                        - |      |
|  Performance Cash            |                        561,163                                                                   |  (9) |              561,163                                                                   |  (9)      |            561,163                                                                   |  (9) |
|  Stock Options               |                      244,020                                                                               |  (6) |           244,020                                                                                     |  (6)      |          244,020                                                                               |  (6) |
|  Restricted Stock Units      |                      670,980                                                                               |  (6) |            670,980                                                                               |  (6)      |          670,980                                                                               |  (6) |
|  Long-Term Performance Award |                        40,338                                                                    | (9)       |              40,338                                                                    |  (9)      |            40,338                                                                    |  (9) |
|  Non-compete Consideration   |                                    - |      |                          - |           |                        - |      |
|  Total                       |  $                1,516,501                                                                                                                                            |      |  $      2,184,183                                                                                                                   |           |  $    1,625,226                                                                                                              |      |

|  | (1) | Represents 18 months of NEO's base salary to be paid monthly following the NEO's termination or disability. |
|--|-----|-------------------------------------------------------------------------------------------------------------|

|  | (2) | Represents the Company's portion of the NEO's private health insurance contributions to be paid for 18 months following the NEO's termination or disability. |
|--|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (3) | Following a termination (a) without cause, (b) for good reason, (c) without cause or for good reason within 12 months of a change in control, or (d) because of death, the NEO is entitled to receive a pro-rata portion of any bonus to which the NEO is otherwise entitled as of the date of termination.  Based on the Company's international group performance for 2013, the NEO was entitled to a bonus as of December 31, 2013.  No additional incentive amounts would be paid during the severance period. |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (4) | The NEO is entitled to lease a company car with a monthly leasing rate of 1,000 Euros, or receive the equivalent value in cash.  Following a termination (a) without cause, (b) for good reason, or (c) without cause or for good reason within 12 months of a change in control, the NEO is entitled to a company car for a period of 18 months following the NEO's termination. |
|--|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (5) | Mr. Choueiri's performance-based cash award for 2013 had a one-year measurement period and was not earned for 2013.  With the exception of accelerated vesting due to certain termination events described in footnote 9 below, Mr. Choueiri's performance-based cash award would be forfeited upon Mr. Choueiri's separation from service. |
|--|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (6) | Following a change in control or a termination (a) without cause, (b) for good reason, (c) without cause or for good reason within 12 months of a change in control, or (d) because of disability or death, unvested equity awards will vest and remain exercisable in accordance with the terms of the applicable award agreements.  The values in the table are based upon the difference between the Company's closing stock price on December 31, 2013 of $15.35 per share and the exercise price of the awards, including only those awards whose exercise price was below the market price on December 31, 2013.  RSUs have an exercise price of zero. |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (7) | During 2011, Mr. Choueiri was granted a long-term performance award in which he earned a fixed percentage of revenue growth in the international business for 2011.  Based on 2011 revenue growth in the international business, Mr. Choueiri earned an award of approximately $117,000.  This award vests and is paid ratably over three years on each anniversary of the grant date (one-third of the award vests on each of January 1, 2012, 2013, and 2014).  With the exception of accelerated vesting due to certain termination events described in footnote 9 below, the award would be forfeited upon Mr. Choueiri's separation from service. |
|--|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|  | (8) | As consideration for the 12-month non-competition and non-solicitation period following Mr. Choueiri's termination of employment, he is entitled to receive 50% of his most recent remuneration related to certain compensation elements.  The amount in the table equals 50% of his earnings in 2013 related to the following specified compensation elements: base salary, medical benefits, annual incentive award, performance-based cash award, car allowance, and pension fund contributions. |
|--|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (9) | Mr. Choueiri's performance-based cash award for 2013 and 2012 and his long-term performance award for 2011 would fully vest upon a change in control or upon Mr. Choueiri's death or disability (to the extent not previously forfeited).  The amount in the table equals one-third of his 2011 long-term performance award (which was fully earned in 2011 but vests in three equal annual installments beginning in January 2012); and two-thirds of his 2012 performance-based cash award (which was fully earned in and reported in the Summary Compensation Table for 2012 but vests in three equal annual installments beginning in January 2013).  Mr. Choueiri's performance-based cash award for 2013 had a one-year measurement period and was not earned. |
|--|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (10) | Although not reflected in this table, if Mr. Choueiri's disability were work-related, the Company would be reimbursed for approximately 15% of this amount by public and private insurance.  In addition to the amount reflected in this table, in the event of disability, the NEO would receive a lump sum of approximately $185,000 from a third party support fund. |
|--|------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|                            | Involuntary Without                                                                                                                                                                                                |      |                                                                                                                      |      | Voluntary                                                                                                                                               |      |
|---------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------|---------------------------------------------------------------------------------------------------------------------------|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------|-----------|
|                            | Cause or Voluntary                                                                                                                                                                                                 |      | Involuntary                                                                                                               |      | Without Good                                                                                                                                            |      |
|                            | For Good Reason                                                                                                                                                                                                    |      | For Cause                                                                                                                 |      | Reason                                                                                                                                                  |      |
|                            | on 12/31/13                                                                                                                                                                                                        |      | on 12/31/13                                                                                                               |      | on 12/31/13                                                                                                                                             |      |
|                            |                                                                                                                                                                                                               |      |                                                                                                                      |      |                                                                                                                                                    |      |
|  Cash Severance            |  $                         1,050,000                                                                                                         |  (1) |  $                -                                                          |      |  $           26,923                                                                                                  |  (2) |
|  Group Medical Benefits    |                                   25,483 |  (3) |                     - |      |                      653                       |  (2) |
|  Long-term Incentive Award |                                 500,000            |  (4) |                     - |      |                          - |      |
|  Additional Severance      |                                 350,000            |  (5) |         350,000                                                                   |  (5) |                          - |      |
|  Total                     |  $                         1,925,483                                                                                                         |      |  $    350,000                                                                                              |      |  $           27,576                                                                                                  |      |
|                            |                                                                                                                                                    |   | Involuntary Without                                                                                                                                                      |      |                                                                                                          |          |                                                                                                                      |   |
|---------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------|---------------------------------------------------------------------------------------------------------------|---------------|---------------------------------------------------------------------------------------------------------------------------|--------|
|                            |                                                                                                                                                    |   |  Cause or Voluntary For                                                                                                                                             |      |                                                                                                          |          |                                                                                                                      |   |
|                            |                                                                                                                                                    |   | Good Reason                                                                                                                                                              |      |                                                                                                          |          |                                                                                                                      |   |
|                            | Change                                                                                                                                                  |   | Within 12 Months of a                                                                                                                                                    |      |                                                                                                          |          |                                                                                                                      |   |
|                            | in Control                                                                                                                                              |   | Change in Control                                                                                                                                                        |      | Disability                                                                                                    |          | Death                                                                                                                     |   |
|                            | on 12/31/13                                                                                                                                             |   | on 12/31/13                                                                                                                                                              |      | on 12/31/13                                                                                                   |          | on 12/31/13                                                                                                               |   |
|                            |                                                                                                                                                    |   |                                                                                                                                                                     |      |                                                                                                          |          |                                                                                                                      |   |
|  Cash Severance            |  $                      -                                                                   |   |  $                   1,050,000                                                                                    |  (1) |  $1,050,000                                                                                              |  (6) (1) |  $                 -                                                    |   |
|  Group Medical Benefits    |                          - |   |                            25,483 |  (3) |         33,978                                                        |  (3)     |                     - |   |
|  Long-term Incentive Award |                          - |   |                          500,000            |  (4) |                   - |          |                     - |   |
|  Additional Severance      |                          - |   |                          350,000            | (5)       |       350,000                                                                   | (5)           |                     - |   |
|  Total                     |  $                      -                                                                   |   |  $                   1,925,483                                                                                    |      |  $1,433,978                                                                                              |          |  $                 -                                                    |   |

----

|  | (1) | Represents 18 months of NEO's base salary to be paid at regular payroll dates following the NEO's termination.  Following a change in control, the payments would be paid in a lump sum no later than 60 days following the date of termination. |
|--|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (2) | For termination by the NEO without good reason, the NEO is entitled to base salary and benefits through the next payroll date following termination. |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (3) | Represents the Company's portion of premiums for group medical benefits to be paid for 18 months following the NEO's termination.  For termination due to disability, represents the Company's portion of premiums for group medical benefits to be paid for 24 months following the NEO's termination. |
|--|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (4) | Mr. Farris was granted incentive compensation based on achieving annual targets for each of 2012, 2013, and 2014.  Following a termination (a) without cause, (b) for good reason, or (c) without cause or for good reason within 12 months of a change in control, Mr. Farris is eligible to receive a pro-rata portion of this incentive compensation as determined by the Company. The value in the table represents the portion of the incentive compensation that was earned but not vested as of December 31, 2013. |
|--|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (5) | Assumes execution of full release of claims in favor of the Company.  Represents six months of the NEO's base salary to be paid at regular payroll dates following the NEO's termination. |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (6) | Although not reflected in this table, this amount would be reduced by any disability insurance payments paid by the insurance company to the NEO as a result of the NEO's disability.  In the event of disability, the NEO would receive $12,000 per each month of disability from the insurance company until the approximate age of 67. |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|                            | Involuntary Without                                                                                                                                                                                                                                                       |      |                                                                                                                      |   | Voluntary                                                                                                                                               |      |
|---------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------|---------------------------------------------------------------------------------------------------------------------------|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------|-----------|
|                            | Cause or Voluntary                                                                                                                                                                                                                                                        |      | Involuntary                                                                                                               |   | Without Good                                                                                                                                            |      |
|                            | For Good Reason                                                                                                                                                                                                                                                           |      | For Cause                                                                                                                 |   | Reason                                                                                                                                                  |      |
|                            | on 12/31/13                                                                                                                                                                                                                                                               |      | on 12/31/13                                                                                                               |   | on 12/31/13                                                                                                                                             |      |
|                            |                                                                                                                                                                                                                                                                      |      |                                                                                                                      |   |                                                                                                                                                    |      |
|  Cash Severance            |  $                            386,250                                                                                                                                                          |  (1) |  $                -                                                          |   |  $             9,904                                                                                            |  (2) |
|  Group Medical Benefits    |                                    25,431                                                  |  (3) |                     - |   |                      652                       |  (2) |
|  Annual Incentive Award    |                                             - |  (4) |                     - |   |                          - |      |
|  Performance Cash          |                                             - |  (5) |                     - |   |                          - |      |
|  Stock Options             |                                   271,172                                                       | (6)       |                     - |   |                          - |      |
|  Restricted Stock Units    |                                 399,269                                                                   | (6)       |                     - |   |                          - |      |
|  Capital Accumulation Plan |                                   76,868                                                        | (7)       |                     - |   |                          - |      |
|  Additional Severance      |                                  128,750                                                             | (8)       |          128,750                                                             | (8)    |                          - |      |
|  Total                     |  $                         1,287,740                                                                                                                                                                |      |  $     128,750                                                                                        |   |  $            10,556                                                                                                 |      |

----

|                            |                                                                                                                                                    |       | Involuntary Without                                                                                                                                                                                                             |       |                                                                                                          |          |                                                                                                                      |   |
|---------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------|------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|---------------------------------------------------------------------------------------------------------------|---------------|---------------------------------------------------------------------------------------------------------------------------|--------|
|                            |                                                                                                                                                    |       |  Cause or Voluntary For                                                                                                                                                                                                    |       |                                                                                                          |          |                                                                                                                      |   |
|                            |                                                                                                                                                    |       | Good Reason                                                                                                                                                                                                                     |       |                                                                                                          |          |                                                                                                                      |   |
|                            |                                                                                                                                                    |       | Within 12 Months of a                                                                                                                                                                                                           |       |                                                                                                          |          |                                                                                                                      |   |
|                            | Change in Control                                                                                                                                       |       | Change in Control                                                                                                                                                                                                               |       | Disability                                                                                                    |          | Death                                                                                                                     |   |
|                            | on 12/31/13                                                                                                                                             |       | on 12/31/13                                                                                                                                                                                                                     |       | on 12/31/13                                                                                                   |          | on 12/31/13                                                                                                               |   |
|                            |                                                                                                                                                    |       |                                                                                                                                                                                                                            |       |                                                                                                          |          |                                                                                                                      |   |
|  Cash Severance            |  $                      -                                                                   |       |  $                      386,250                                                                                                                                     | (1)        |  $   386,250                                                                                   |  (9) (1) |  $                 -                                                    |   |
|  Group Medical Benefits    |                          - |       |                             25,431                                                  | (3)        |         33,908                                                        | (3)           |                     - |   |
|  Annual Incentive Award    |                          - |       |                                      - | (4)        |                   - | (4)           |                     - | (4)    |
|  Performance Cash          |                125,500                                                       |  (10) |                           125,500                                                             |  (10) |                   - | (5)           |                     - | (5)    |
|  Stock Options             |                 271,172                                                 | (6)        |                            271,172                                                       | (6)        |         271,172                                                       | (6)           |            271,172                                                 | (6)    |
|  Restricted Stock Units    |              399,269                                                                   | (6)        |                         399,269                                                                         | (6)        |      399,269                                                                         | (6)           |         399,269                                                                   | (6)    |
|  Capital Accumulation Plan |                 76,868                                                  | (7)        |                            76,868                                                        | (7)        |         76,868                                                        | (7)           |            76,868                                                  | (7)    |
|  Additional Severance      |                          - |       |                           128,750                                                             | (8)        |        128,750                                                             |  (8)     |                     - |   |
|  Total                     |  $          872,809                                                                                                       |       |  $                    1,413,240                                                                                                                                          |       |  $ 1,296,217                                                                                             |          |  $      747,309                                                                                       |   |

|  | (1) | Represents 18 months of NEO's base salary to be paid at regular payroll dates following the NEO's termination.  Following a change in control, the payments would be paid in a lump sum no later than 60 days following the date of termination. |
|--|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (2) | For termination by the NEO without good reason, the NEO is entitled to base salary and benefits through the next payroll date following termination. |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (3) | Represents the Company's portion of premiums for group medical benefits to be paid for 18 months following the NEO's termination.  For termination due to disability, represents the Company's portion of premiums for group medical benefits to be paid for 24 months following the NEO's termination. |
|--|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (4) | Following a termination (a) without cause, (b) for good reason, (c) without cause or for good reason within 12 months of a change in control, or (d) because of disability or death, the NEO is entitled to receive a pro-rata portion of any bonus to which the NEO is otherwise entitled as of the date of termination.  Based on Company performance for 2013, the NEO was not entitled to a bonus as of December 31, 2013.  No additional incentive amounts would be paid during the severance period. |
|--|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (5) | Following a termination (a) without cause, (b) for good reason, (c) in connection with a normal or early retirement, or (d) because of disability or death, the NEO is entitled to receive any amounts previously earned by the NEO under the Company's performance-based cash incentive plan, which would include the earned amount for year one of the 2013 award, years one and two of the 2012 award, and years one through three of the 2011 award.  Based on Company performance, no amounts were earned by the NEO for these performance periods.  With the exception of the accelerated vesting due to the termination events described in the table, the performance-based cash award vests on the third anniversary of the grant date. |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (6) | Following a change in control or a termination (a) without cause, (b) for good reason, (c) without cause or for good reason within 12 months of a change in control, or (d) because of disability or death, unvested equity awards will vest and remain exercisable in accordance with the terms of the applicable award agreements.  The values in the table are based upon the difference between the Company's closing stock price on December 31, 2013 of $15.35 per share and the exercise price of the awards, including only those awards whose exercise price was below the market price on December 31, 2013.  RSUs have an exercise price of zero. |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (7) | Following a change in control or a termination (a) without cause, (b) for good reason, (c) without cause or for good reason within 12 months of a change in control, (d) because of disability or death, or (e) in connection with a normal or early retirement, all amounts contributed by the Company to the CAP for the benefit of the NEO will vest.  The amount in the table above reflects the NEO's aggregate CAP balance as of December 31, 2013, $71,734 of which was vested, and excludes Company contributions attributable to 2013 as they were not made until fiscal 2014.  The remaining portion was unvested at December 31, 2013, but would vest upon termination of the NEO for the reasons listed in clauses (a) through (e) above. |
|--|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|  | (8) | Assumes execution of full release of claims in favor of the Company.  Represents six months of the NEO's base salary to be paid at regular payroll dates following the NEO's termination. |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (9) | Although not reflected in this table, this amount would be reduced by any disability insurance payments paid by the insurance company to the NEO as a result of the NEO's disability.  In the event of disability, the NEO would receive $12,000 per each month of disability from the insurance company until reaching age 67. |
|--|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (10) | Following a change in control, all amounts granted under the Company's performance-based cash incentive plan would vest (to the extent not previously forfeited). |
|--|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|                            | Involuntary Without                                                                                                                                                                                                                                                       |      |                                                                                                                      |   | Voluntary                                                                                                                                               |      |
|---------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------|---------------------------------------------------------------------------------------------------------------------------|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------|-----------|
|                            | Cause or Voluntary                                                                                                                                                                                                                                                        |      | Involuntary                                                                                                               |   | Without Good                                                                                                                                            |      |
|                            | For Good Reason                                                                                                                                                                                                                                                           |      | For Cause                                                                                                                 |   | Reason                                                                                                                                                  |      |
|                            | on 12/31/13                                                                                                                                                                                                                                                               |      | on 12/31/13                                                                                                               |   | on 12/31/13                                                                                                                                             |      |
|                            |                                                                                                                                                                                                                                                                      |      |                                                                                                                      |   |                                                                                                                                                    |      |
|  Cash Severance            |  $                            386,250                                                                                                                                                          |  (1) |  $                -                                                          |   |  $             9,904                                                                                            |  (2) |
|  Group Medical Benefits    |                                    25,431                                                  |  (3) |                     - |   |                      652                       |  (2) |
|  Annual Incentive Award    |                                             - |  (4) |                     - |   |                          - |      |
|  Performance Cash          |                                             - |  (5) |                     - |   |                          - |      |
|  Stock Options             |                                   79,370                                                        | (6)       |                     - |   |                          - |      |
|  Restricted Stock Units    |                                  185,259                                                             | (6)       |                     - |   |                          - |      |
|  Capital Accumulation Plan |                                    43,391                                                  | (7)       |                     - |   |                          - |      |
|  Additional Severance      |                                  128,750                                                             | (8)       |          128,750                                                             | (8)    |                          - |      |
|  Total                     |  $                             848,451                                                                                                                                                    |      |  $     128,750                                                                                        |   |  $            10,556                                                                                                 |      |

|                            |                                                                                                                                                    |       | Involuntary Without                                                                                                                                                                                                       |       |                                                                                                    |          |                                                                                                                      |      |
|---------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------|------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|---------------------------------------------------------------------------------------------------------|---------------|---------------------------------------------------------------------------------------------------------------------------|-----------|
|                            |                                                                                                                                                    |       |  Cause or Voluntary For                                                                                                                                                                                              |       |                                                                                                    |          |                                                                                                                      |      |
|                            |                                                                                                                                                    |       | Good Reason                                                                                                                                                                                                               |       |                                                                                                    |          |                                                                                                                      |      |
|                            | Change                                                                                                                                                  |       | Within 12 Months of a                                                                                                                                                                                                     |       |                                                                                                    |          |                                                                                                                      |      |
|                            | in Control                                                                                                                                              |       | Change in Control                                                                                                                                                                                                         |       | Disability                                                                                              |          | Death                                                                                                                     |      |
|                            | on 12/31/13                                                                                                                                             |       | on 12/31/13                                                                                                                                                                                                               |       | on 12/31/13                                                                                             |          | on 12/31/13                                                                                                               |      |
|                            |                                                                                                                                                    |       |                                                                                                                                                                                                                      |       |                                                                                                    |          |                                                                                                                      |      |
|  Cash Severance            |  $                      -                                                                   |       |  $                     386,250                                                                                                                                |  (1)  |  $  386,250                                                                                   |  (9) (1) |  $                 -                                                    |      |
|  Group Medical Benefits    |                          - |       |                            25,431                                                  |  (3)  |        33,908                                                        |  (3)     |                     - |      |
|  Annual Incentive Award    |                          - |       |                                     - |  (4)  |                  - |  (4)     |                     - |  (4) |
|  Performance Cash          |              108,000                                                                   |  (10) |                         108,000                                                                   |  (10) |                  - |  (5)     |                     - |  (5) |
|  Stock Options             |                 79,370                                                  | (6)        |                            79,370                                                  | (6)        |         79,370                                                  | (6)           |            79,370                                                  | (6)       |
|  Restricted Stock Units    |               185,259                                                             | (6)        |                          185,259                                                             | (6)        |        185,259                                                       | (6)           |           185,259                                                       | (6)       |
|  Capital Accumulation Plan |                 43,391                                                  | (7)        |                            43,391                                                  | (7)        |         43,391                                                  | (7)           |            43,391                                                  | (7)       |
|  Additional Severance      |                          - |       |                          128,750                                                             | (8)        |        128,750                                                       |  (8)     |                     - |      |
|  Total                     |  $          416,020                                                                                                       |       |  $                      956,451                                                                                                                               |       |  $  856,928                                                                                   |          |  $     308,020                                                                                        |      |

----

|  |  (1) | Represents 18 months of NEO's base salary to be paid at regular payroll dates following the NEO's termination.  Following a change in control, the payments would be paid in a lump sum no later than 60 days following the date of termination. |
|--|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (2) | For termination by the NEO without good reason, the NEO is entitled to base salary and benefits through the next payroll date following termination. |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (3) | Represents the Company's portion of premiums for group medical benefits to be paid for 18 months following the NEO's termination.  For termination due to disability, represents the Company's portion of premiums for group medical benefits to be paid for 24 months following the NEO's termination. |
|--|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (4) | Following a termination (a) without cause, (b) for good reason, (c) without cause or for good reason within 12 months of a change in control, or (d) because of disability or death, the NEO is entitled to receive a pro-rata portion of any bonus to which the NEO is otherwise entitled as of the date of termination.  Based on Company performance for 2013, the NEO was not entitled to a bonus as of December 31, 2013.  No additional incentive amounts would be paid during the severance period. |
|--|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (5) | Following a termination (a) without cause, (b) for good reason, (c) in connection with a normal or early retirement, or (d) because of disability or death, the NEO is entitled to receive any amounts previously earned by the NEO under the Company's performance-based cash incentive plan, which would include the earned amount for year one of the 2013 award, years one and two of the 2012 award, and years one through three of the 2011 award.  Based on Company performance, no amounts were earned by the NEO for these performance periods.  With the exception of the accelerated vesting due to the termination events described in the table, the performance-based cash award vests on the third anniversary of the grant date. |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (6) | Following a change in control or a termination (a) without cause, (b) for good reason, (c) without cause or for good reason within 12 months of a change in control, or (d) because of disability or death, unvested equity awards will vest and remain exercisable in accordance with the terms of the applicable award agreements.  The values in the table are based upon the difference between the Company's closing stock price on December 31, 2013 of $15.35 per share and the exercise price of the awards, including only those awards whose exercise price was below the market price on December 31, 2013.  RSUs have an exercise price of zero. |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (7) | Following a change in control or a termination (a) without cause, (b) for good reason, (c) without cause or for good reason within 12 months of a change in control, (d) because of disability or death, or (e) in connection with a normal or early retirement, all amounts contributed by the Company to the CAP for the benefit of the NEO will vest.  The amount in the table above reflects the NEO's aggregate CAP balance as of December 31, 2013, $43,263 of which was vested, and excludes Company contributions attributable to 2013 as they were not made until fiscal 2014.  The remaining portion was unvested at December 31, 2013, but would vest upon termination of the NEO for the reasons listed in clauses (a) through (e) above. |
|--|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (8) | Assumes execution of full release of claims in favor of the Company.  Represents six months of the NEO's base salary to be paid at regular payroll dates following the NEO's termination. |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (9) | Although not reflected in this table, this amount would be reduced by any disability insurance payments paid by the insurance company to the NEO as a result of the NEO's disability.  In the event of disability, the NEO would receive $12,000 per each month of disability from the insurance company until reaching age 67. |
|--|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (10) | Following a change in control, all amounts granted under the Company's performance-based cash incentive plan would vest (to the extent not previously forfeited). |
|--|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| Name                    | Fees Earned orPaid inCash($) | Stock Awards($) | OptionAwards($) | Total($)       |
|-------------------------|------------------------------|-----------------|-----------------|----------------|
|                    |                         | (1)             | (2)             |           |
| John W. Ballantine      | $200,000                | $50,003         | $50,012    | $300,015  |
| Thomas G. Cigarran      | 125,000                 | 50,003          | 50,012     | 225,015   |
| Jay C. Bisgard, M.D.    | 107,500                 | 50,003          | 50,012     | 207,515   |
| Mary Jane England, M.D. | 99,500                  | 50,003          | 50,012     | 199,515   |
| C. Warren Neel, Ph.D.   | 148,000                 | 50,003          | 50,012     | 248,015   |

----

| William D. Novelli          | 100,500  | 50,003  | 50,012  | 200,515  |
|-----------------------------|---------------|--------------|--------------|---------------|
| William C. O'Neil, Jr.      | 44,958   | -            | -       | 44,958   |
| Alison Taunton-Rigby, Ph.D. | 109,000  | 50,003       | 50,012  | 209,015  |
| Donato J. Tramuto           | 38,667   | -            | 114,900      | 153,567       |
| John A. Wickens             | 100,000  | 50,003       | 50,012  | 200,015  |
| Kevin G. Wills              | 100,000  | 50,003       | 50,012  | 200,015  |

| (1) | Reflects the aggregate grant date fair value of stock awards granted during 2013 calculated in accordance with FASB ASC Topic 718.  The grant date fair value of stock awards granted to the Outside Directors during 2013 was $13.94 per award. The following directors had unvested stock awards outstanding as of December 31, 2013:  Mr. Ballantine (11,755); Mr. Cigarran (11,755); Dr. Bisgard (11,755); Dr. England (11,755); Dr. Neel (11,755); Mr. Novelli (10,873); Mr. O'Neil (8,168); Dr. Taunton-Rigby (11,755); Mr. Wickens (11,755) and Mr. Wills (3,587).   Upon resignation in February 2014, Mr. Cigarran's unvested stock awards were cancelled. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2) | Reflects the aggregate grant date fair value of stock option awards granted during 2013 calculated in accordance with FASB ASC Topic 718.  The grant date fair value of stock options granted to the Outside Directors during 2013 was $7.66 per stock option.  Assumptions used in the calculation of these amounts are disclosed in Note 13 to our audited financial statements for the fiscal year ended December 31, 2013, included in our Original Form 10-K.  The following directors had stock option awards outstanding as of December 31, 2013:  Mr. Ballantine (56,998); Mr. Cigarran (41,998); Dr. Bisgard (56,998); Dr. England (66,998); Dr. Neel (56,998); Mr. Novelli (40,958); Mr. O'Neil (50,469); Dr. Taunton-Rigby (46,998); Mr. Tramuto (15,000), Mr. Wickens (56,998); and Mr. Wills (21,529). Of Mr. Cigarran's options outstanding as of December 31, 2013, 21,234 of unvested options were cancelled in February 2014 upon his resignation. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| Name and Address of Beneficial Owner                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | Amount and Nature of Beneficial Ownership (1) | Percent of Class (1) |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------|----------------------|
| Prudential Financial, Inc751 Broad StreetNewark, NJ 07102-3777                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 5,568,014 (2)                                 | 15.80%               |
| North Tide Capital, LLC                                                                                                                500 Boylston Street      Suite 310      Boston, MA 02116  | 3,850,000 (3)                                 | 10.93%               |
| BlackRock, Inc.                                                                                                          40 East 52nd StreetNew York, NY 10022                                                                                                                             | 3,254,885 (4)                                 | 9.24%                |
| EARNEST Partners, LLC1180 Peachtree Street NE      Suite 2300Atlanta, GA 30309                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 2,756,961 (5)                                 | 7.82%                |
| The Vanguard Group100 Vanguard BoulevardMalvern, PA 19355                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 2,110,311 (6)                                 | 5.99%                |
| Dimensional Fund Advisors LPPalisades West, Building One6300 Bee Cave Road      Austin, TX 78746                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 1,933,320 (7)                                 | 5.49%                |
| Wells Fargo & Company                                                                                                           420 Montgomery Street      San Francisco, CA 94104                                                                  | 1,878,623 (8)                                 | 5.33%                |
| Ben R. Leedle, Jr.****                                                                                                                                                                                                                                                                     | 1,242,814 (9)                                 | 3.43%                |
| Michael Farris***                                                                                                                                                                                                                                                                          | 389,932 (10)                                  | 1.11%                |
| Alfred Lumsdaine***                                                                                                                                                                                                                                                                                                 | 147,579 (11)                                  | *                    |
| Daniel J. Englander**                                                                                                                                                                                                                                                                           | 115,000 (12)                             | *                    |
| C. Warren Neel, Ph.D**                                                                                                                                                                                                                                                                     | 97,105 (13)                                   | *                    |
| Peter Choueiri***                                                                                                                                                                                                                                                                                              | 92,486 (14)                              | *                    |
| John W. Ballantine**.                                                                                                                                                                                                                                                                      | 72,475 (15)                                   | *                    |
| Mary Jane England, M.D.**                                                                                                                                                                                                                                                                  | 65,611 (16)                                   | *                    |

----

| Jay C. Bisgard, M.D.**                                                                                                                                   | 64,624 (17)    | *     |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------|-------|
| Alison Taunton-Rigby, Ph. D.**                                                                                                            | 55,919 (18)    | *     |
| John A. Wickens**                                                                                                                         | 57,475 (19)    | *     |
| Glenn Hargreaves***                                                                                                                       | 49,520 (20)    | *     |
| William D. Novelli**                                                                                                                      | 31,191 (21)    | *     |
| Mary Flipse***                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 14,674 (22)    | *     |
| Kevin G. Wills**                                                                                                                          | 9,132 (23)     | *     |
| Donato Tramuto**                                                                                                                          | 7,950 (24)     | *     |
| All directors and executive officers as a group (16 persons)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 2,511,762 (25) | 6.84% |

| (1) | Pursuant to the rules of the Commission, certain shares of our Common Stock that an individual owner set forth in this table has a right to acquire within 60 days after April 10, 2014 pursuant to the exercise of options to purchase shares of Common Stock ("stock options") or other securities are deemed to be outstanding for the purpose of computing the ownership of that owner, but are not deemed outstanding for the purpose of computing the ownership of any other individual owner shown in the table.  Likewise, the shares subject to stock options or other securities held by our other directors and executive officers that are exercisable within 60 days of April 10, 2014 are all deemed outstanding for the purpose of computing the percentage ownership of all executive officers and directors as a group. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2) | Information with respect to stock ownership is based on a Schedule 13G/A filed by Prudential Financial, Inc. ("Prudential") with the Commission on January 29, 2014 and includes shares held by certain of its subsidiaries, including Jennison Associates LLC ("Jennison").  Includes 105,304 shares to which Prudential has sole voting power, 5,462,710 shares to which Prudential has shared voting power, 105,304 shares to which Prudential has sole investment power and 5,462,710 shares to which Prudential has shared investment power. Jennison filed a separate Schedule13G/A with the Commission on February 12, 2014 reporting beneficial ownership of 5,477,265 shares to which Jennison has sole voting power and shared investment power. These shares have not been listed separately because they are included in the shares reported by Prudential, which indirectly owns 100% of the equity interests of Jennison. The address of Jennison is 466 Lexington Avenue, New York, New York 10017. |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (3) | Information with respect to stock ownership is based on a Schedule 13D/A filed with the Commission on March 3, 2014. Includes 3,850,000 shares to which North Tide Capital, LLC has shared voting and investment power. Includes 3,425,000 shares to which North Tide Capital Master, LP has shared voting and investment power. Includes 3,850,000 shares to which Conan Laughlin, who serves as the Manager of North Tide Capital, LLC, has shared voting and investment power.  The address of North Tide Capital Master, LP and Conan Laughlin is 500 Boylston Street, Suite 310, Boston, Massachusetts, 02116. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (4) | Information with respect to stock ownership is based on a Schedule 13G/A filed by BlackRock, Inc. with the Commission on January 29, 2014 and includes shares held by certain of its subsidiaries.  Includes 3,142,378 shares to which BlackRock, Inc. has sole voting power and 3,254,885 shares to which BlackRock, Inc. has sole investment power. |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (5) | Information with respect to stock ownership is based on a Schedule 13G/A filed with the Commission on February 14, 2014. Includes 1,164,444 shares to which EARNEST Partners, LLC ("EARNEST") has sole voting power, 379,742 shares to which EARNEST has shared voting power and 2,756,961 shares to which EARNEST has sole investment power. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| (6) | Information with respect to stock ownership is based on a Schedule 13G/A filed by The Vanguard Group, Inc. ("Vanguard") with the Commission on February 11, 2014 and includes shares held by certain of its subsidiaries. Includes 54,994 shares to which Vanguard has sole voting power, 2,057,217 shares to which Vanguard has sole investment power and 53,094 shares to which Vanguard has shared investment power. |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (7) | Information with respect to stock ownership is based on a Schedule 13G filed with the Commission on February 10, 2014. Includes 1,865,966 shares to which Dimensional Fund Advisors LP ("Dimensional") has sole voting power and 1,933,320 shares to which Dimensional has shared investment power. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (8) | Information with respect to stock ownership is based on a Schedule 13G/A filed by Wells Fargo & Company ("WFC") with the Commission on January 28, 2014 and includes shares held by certain of its subsidiaries. Includes 116 shares to which WFC has sole voting power, 1,873,010 shares to which WFC has shared voting power, 116 shares to which WFC has sole investment power and 1,878,507 shares to which WFC has shared investment power. |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (9) | Includes 985,916 shares that, as of April 10, 2014, were issuable upon the exercise of outstanding stock options within 60 days after April 10, 2014. |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------|

| (11) | Includes 113,567 shares that, as of April 10, 2014, were issuable upon the exercise of outstanding stock options within 60 days after April 10, 2014. |
|------|-------------------------------------------------------------------------------------------------------------------------------------------------------|

| (12) | Consists of 115,000 shares held indirectly with Ursula Capital Partners, of which Mr. Englander is the Managing Partner. Mr. Englander disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. |
|------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (13) | Includes 43,764 shares that, as of April 10, 2014, were issuable upon the exercise of outstanding stock options within 60 days after April 10, 2014. |
|------|------------------------------------------------------------------------------------------------------------------------------------------------------|

| (14) | Includes 74,754 shares that, as of April 10, 2014, were issuable upon the exercise of outstanding stock options within 60 days after April 10, 2014. |
|------|------------------------------------------------------------------------------------------------------------------------------------------------------|

| (15) | Includes 43,764 shares that, as of April 10, 2014, were issuable upon the exercise of outstanding stock options within 60 days after April 10, 2014, and 20,000 shares held in trust. |
|------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (16) | Includes 53,764 shares that, as of April 10, 2014, were issuable upon the exercise of outstanding stock options within 60 days after April 10, 2014. |
|------|------------------------------------------------------------------------------------------------------------------------------------------------------|

| (17) | Includes 43,764 shares that, as of April 10, 2014, were issuable upon the exercise of outstanding stock options within 60 days after April 10, 2014, and 20,860 shares held in trust. |
|------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (18) | Includes 33,764 shares that, as of April 10, 2014, were issuable upon the exercise of outstanding stock options within 60 days after April 10, 2014. |
|------|------------------------------------------------------------------------------------------------------------------------------------------------------|

| (19) | Includes 43,764 shares that, as of April 10, 2014, were issuable upon the exercise of outstanding stock options within 60 days after April 10, 2014, and 1,100 shares held jointly by Mr. Wickens and his spouse. |
|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (20) | Includes 40,497 shares that, as of April 10, 2014, were issuable upon the exercise of outstanding stock options within 60 days after April 10, 2014. |
|------|------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| (21) | Includes 27,724 shares that, as of April 10, 2014, were issuable upon the exercise of outstanding stock options within 60 days after April 10, 2014. |
|------|------------------------------------------------------------------------------------------------------------------------------------------------------|

| (22) | Includes 11,784 shares that, as of April 10, 2014, were issuable upon the exercise of outstanding stock options within 60 days after April 10, 2014. |
|------|------------------------------------------------------------------------------------------------------------------------------------------------------|

| (23) | Consists of 9,132 shares that, as of April 10, 2014, were issuable upon the exercise of outstanding stock options within 60 days after April 10, 2014. |
|------|--------------------------------------------------------------------------------------------------------------------------------------------------------|

| (24) | Includes 3,750 shares that, as of April 10, 2014, were issuable upon the exercise of outstanding stock options within 60 days after April 10, 2014. |
|------|-----------------------------------------------------------------------------------------------------------------------------------------------------|

| (25) | Includes 1,529,708 shares that, as of April 10, 2014, were issuable upon the exercise of outstanding stock options within 60 days after April 10, 2014. |
|------|---------------------------------------------------------------------------------------------------------------------------------------------------------|

| Plan Category                                          | Number of Shares to be Issued Upon Exercise ofOutstanding Options, Warrants and Rights,in thousands(1) |  | Weighted-AverageExercise Price ofOutstanding Options, Warrants and Rights(2) |  | Number of SharesRemaining Available forFuture Issuance UnderEquity Compensation Plans(Excluding Shares Reflectedin First Column),in thousands(3) |
|--------------------------------------------------------|--------------------------------------------------------------------------------------------------------|--|------------------------------------------------------------------------------|--|--------------------------------------------------------------------------------------------------------------------------------------------------|
| Equity compensation plans approved by stockholders     | 5,166                                                                                                  |  | $15.09                                                                       |  | 218                                                                                                                                              |
| Equity compensation plans not approved by stockholders | —                                                                                                |  | —                                                                      |  | —                                                                                                                                          |
| Total                                                  | 5,166                                                                                                  |  | $15.09                                                                       |  | 218                                                                                                                                              |

| (1) | Represents 4,325,000 stock options and 841,000 restricted stock and RSUs granted under the Prior Plans. |
|-----|---------------------------------------------------------------------------------------------------------|

| (2) | The weighted average exercise price does not take into account the shares issuable upon vesting of outstanding unvested RSUs, which have no exercise price. The weighted average remaining contractual term of the outstanding stock options is 6.4 years. |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (3) | The number of shares remaining available for future issuance in this column will no longer be available after June 24, 2014 for future grants if the 2014 Plan is approved by stockholders at the 2014 Annual Meeting of Stockholders. Any grants occurring after March 25, 2014 under the Prior Plans will reduce the number of shares of Common Stock available for issuance under the 2014 Plan. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| Item 13. | Certain Relationships and Related Transactions, and Director Independence |
|----------|---------------------------------------------------------------------------|

| · | the aggregate amount involved exceeded, or will or may be expected to exceed, $120,000 in any calendar year; |
|--------|--------------------------------------------------------------------------------------------------------------|

| · | the Company was, is or will be a participant; and |
|--------|---------------------------------------------------|

| · | any Related Party had, has or will have a direct or indirect material interest. |
|--------|---------------------------------------------------------------------------------|

| · | person who is or was (since the beginning of the last fiscal year for which the Company has filed a Form 10-K and Proxy Statement, even if they do not presently serve in that role) an executive officer, director or nominee for election as a director; |
|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| · | greater than 5% beneficial owner of the Company's Common Stock; |
|--------|-----------------------------------------------------------------|

| · | immediate family member of any of the foregoing; or |
|--------|-----------------------------------------------------|

| · | firm, corporation or other entity in which any of the foregoing persons is employed or is a general partner, managing member or principal or in a similar position or in which such person has a 10% or greater beneficial ownership interest. |
|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| Item 14. | Principal Accounting Fees and Services |
|----------|----------------------------------------|

| Type of Service        | Fiscal Year Ended December 31, 2013 | Fiscal Year Ended December 31, 2012 |
|------------------------|-------------------------------------|-------------------------------------|
| Audit Fees             | $1,104,978                          | $957,757                            |
| Audit-Related Fees (1) | 1,995                               | 1,995                               |
| Tax Fees (2)           | 116,650                             | 73,240                              |
| All Other Fees (3)     |     —          |      —    |
| Total                  | $1,223,623                          | $1,032,992                          |

|  | (1) | Audit-Related Fees included subscription fees to an online research tool. |
|--|-----|---------------------------------------------------------------------------|

|  | (2) | For the year ended December 31, 2013 and 2012, tax fees included federal and state tax return compliance and tax advisory services. |
|--|-----|-------------------------------------------------------------------------------------------------------------------------------------|

|  | (3) | All Other Fees consist of fees for services other than services reported above. For the years ended December 31, 2013 and 2012, no services other than those discussed above were provided by Ernst & Young LLP. |
|--|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| Item 15. | Exhibits, Financial Statement Schedules |
|----------|-----------------------------------------|

| (a) | The following documents are filed as part of this Form 10-K/A: |
|-----|----------------------------------------------------------------|

| 2.1    |   | Stock Purchase Agreement dated October 11, 2006 among Healthways, Inc., Axia Health Management, Inc., and Axia Health Management LLC [incorporated herein by reference to Exhibit 2.1 to the Company's Current Report on Form 8-K dated December 1, 2006, File No. 000-19364]                                                                                                                                                    |
|--------|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |   |                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 3.1    |   | Restated Certificate of Incorporation, as amended [incorporated by reference to Exhibit 3.1 to Form 10-Q of the Company's fiscal quarter ended February 29, 2008, File No. 000-19364]                                                                                                                                                                                                                                            |
|   |   |                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 3.2    |   | Certificate of Amendment to Restated Certificate of Incorporation, as amended, dated as of October 10, 2013 [incorporated by reference to Exhibit 3.2 to Form 10-Q of the Company's fiscal quarter ended September 30, 2013, File No. 000-19364]                                                                                                                                                                            |
|   |   |                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 3.3    |   | Amended and Restated Bylaws [incorporated by reference to Exhibit 3.2 to Form 10-Q of the Company's fiscal quarter ended February 29, 2004, File No. 000-19364]                                                                                                                                                                                                                                                                  |
|   |   |                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 3.4    |   | Amendment to Amended and Restated Bylaws [incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K dated November 15, 2007, File No. 000-19364]                                                                                                                                                                                                                                                      |
|   |   |                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 3.5    |   | Amendment No. 2 to Amended and Restated Bylaws [incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K dated September 3, 2008, File No. 000-19364]                                                                                                                                                                                                                                                |
|   |   |                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 4.1    |   | Article IV of the Company's Restated Certificate of Incorporation (included in Exhibit 3.1)                                                                                                                                                                                                                                                                                                                                      |
|   |   |                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 4.2    |   | Rights Agreement dated June 19, 2000 between the Company and SunTrust Bank, including the Form of Rights Certificate (Exhibit A), the Form of Summary of Rights (Exhibit B) and the Form of Certificate of Amendment to the Restated Certificate of Incorporation of the Company (Exhibit C) [incorporated herein by reference to Exhibit 4 to the Company's Current Report on Form 8-K dated June 21, 2000, File No. 000-19364] |
|   |   |                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 4.3    |   | Amendment No. 1 to Rights Agreement dated June 15, 2004 between the Company and SunTrust Bank [incorporated herein by reference to Exhibit 4 to the Company's Current Report on Form 8-K dated June 17, 2004, File No. 000-19364]                                                                                                                                                                                                |

----

| 4.4  |   | Amendment No. 2 to Rights Agreement dated July 19, 2006 between the Company and SunTrust Bank [incorporated herein by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K dated July 19, 2006, File No. 000-19364] |
|-----------|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|      |   |
| 4.5       |   | Indenture dated as of July 8, 2013 between the Company and U.S. Bank National Association [incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K dated July 8, 2013, File No. 000-19364]             |
|      |   |                                                                                                                                                                                                                                |
| 4.6       |   | Form of 1.50% Cash Convertible Senior Note due 2018 (included in Exhibit 4.5)                                                                                                                                                       |
| 10.1   |   | Office Lease dated as of May 4, 2006 between the Company and Highwoods/Tennessee Holdings, L.P. [incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K dated May 5, 2006, File No. 000-19364]                                                                                                                                                                                       |
|--------|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |   |                                                                                                                                                                                                                                                                                                                                                                                                                |
| 10.2   |   | Master Services Agreement dated May 25, 2011 between the Company and HP Enterprise Services, LLC [incorporated by reference to Exhibit 10.1 to Form 10-Q of the Company's fiscal quarter ended June 30, 2011, File No. 000-19364] *                                                                                                                                                                                 |
|   |   |                                                                                                                                                                                                                                                                                                                                                                                                                |
| 10.3   |   | Fifth Amended and Restated Revolving Credit and Term Loan Agreement dated June 8, 2012 between the Company and SunTrust Bank as Administrative Agent, JPMorgan Chase Bank, N.A.as Documentation Agent, and U.S. Bank National Association and Fifth Third Bank as Co-Syndication Agents [incorporated by reference to Exhibit 10.1 to Company's Current Report on Form 8-K dated June 11, 2012, File No. 000-19364] |
|   |   |                                                                                                                                                                                                                                                                                                                                                                                                                |
| 10.4   |   | First Amendment to Fifth Amended and Restated Revolving Credit and Term Loan Agreement dated February 5, 2013 between the Company and SunTrust Bank as Administrative Agent [incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K dated February 7, 2013, File No. 000-19364]                                                                                                      |
|   |   |                                                                                                                                                                                                                                                                                                                                                                                                                |
| 10.5   |   | Second Amendment to Fifth Amended and Restated Revolving Credit and Term Loan Agreement dated March 15, 2013 between the Company and SunTrust Bank as Administrative Agent [incorporated by reference to Exhibit 10.2 to Form 10-Q of the Company's fiscal quarter ended March 31, 2013, File No. 000-19364]                                                                                    |
|   |   |                                                                                                                                                                                                                                                                                                                                                                                                                |
| 10.6   |   | Third Amendment to Fifth Amended and Restated Revolving Credit and Term Loan Agreement and First Amendment to Second Amended and Restated Subsidiary Guarantee Agreement [incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K dated July 1, 2013, File No. 000-19364]                                                                                                             |
|   |   |                                                                                                                                                                                                                                                                                                                                                                                                                |
| 10.7   |   | Call Option Transaction Confirmation dated as of July 1, 2013 between the Company and JPMorgan Chase Bank, National Association, London Branch [incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K dated July 8, 2013, File No. 000-19364]                                                                                                                                       |
|   |   |                                                                                                                                                                                                                                                                                                                                                                                                                |
| 10.8   |   | Amendment to Call Option Transaction Confirmation dated as of July 11, 2013 between the Company and JPMorgan Chase Bank, National Association, London Branch [incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K dated July 16, 2013, File No. 000-19364]                                                                                                                        |
|   |   |                                                                                                                                                                                                                                                                                                                                                                                                                |
| 10.9   |   | Call Option Transaction Confirmation dated as of July 1, 2013 between the Company and Morgan Stanley & Co. International plc [incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K dated July 8, 2013, File No. 000-19364]                                                                                                                                                     |

----

|   |   |                                                                                                                                                                                                                                                                        |
|--------|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 10.10  |   | Amendment to Call Option Transaction Confirmation dated as of July 11, 2013 between the Company and Morgan Stanley & Co. Internal plc [incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K dated July 16, 2013, File No. 000-19364]   |
|   |   |                                                                                                                                                                                                                                                                        |
| 10.11  |   | Base Warrants Confirmation dated as of July 1, 2013 between the Company and JPMorgan Chase Bank, National Association, London Branch [incorporated by reference to Exhibit 10.3 to the Company's Current Report on Form 8-K dated July 8, 2013, File No. 000-19364]         |
|   |   |                                                                                                                                                                                                                                                                        |
| 10.12  |   | Additional Warrants Confirmation dated as of July 11, 2013 between the Company and JPMorgan Chase Bank, National Association, London Branch [incorporated by reference to Exhibit 10.3 to the Company's Current Report on Form 8-K dated July 16, 2013, File No. 000-19364] |
|   |   |                                                                                                                                                                                                                                                                        |
| 10.13  |   | Base Warrants Confirmation dated as of July 1, 2013 between the Company and Morgan Stanley & Co. International plc [incorporated by reference to Exhibit 10.4 to the Company's Current Report on Form 8-K dated July 8, 2013, File No. 000-19364]                       |
|   |   |                                                                                                                                                                                                                                                                        |
| 10.14  |   | Additional Warrants Confirmation dated as of July 11, 2013 between the Company and Morgan Stanley & Co. International plc [incorporated by reference to Exhibit 10.4 to the Company's Current Report on Form 8-K dated July 16, 2013, File No. 000-19364]               |
| 10.15  |   | Investment Agreement dated October 1, 2013 between the Company and CareFirst Holdings, LLC [incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K dated October 2, 2013, File No. 000-19364]*                 |
|--------|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |   |                                                                                                                                                                                                                                          |
| 10.16  |   | Convertible Senior Subordinated Note dated October 1, 2013 issued by the Company to CareFirst Holdings, LLC [incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K dated October 2, 2013, File No. 000-19364] |
| 10.17                                       |   | Form of Common Stock Purchase Warrant [incorporated by reference to Exhibit 10.3 to the Company's Current Report on Form 8-K dated October 2, 2013, File No. 000-19364]                                                                         |
|---------------------------------------------|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                        |   |                                                                                                                                                                                                                                            |
| 10.18                                       |   | Registration Rights Agreement dated October 1, 2013 between the Company and CareFirst Holdings, LLC [incorporated by reference to Exhibit 10.4 to the Company's Current Report on Form 8-K dated October 2, 2013, File No. 000-19364]           |
|                                        |
| Management Contracts and Compensatory Plans |
|                                        |   |                                                                                                                                                                                                                                            |
| 10.19                                       |   | Amended and Restated Employment Agreement dated December 21, 2012 between the Company and Ben R. Leedle, Jr. [incorporated by reference to Exhibit 10.5 to Form 10-K for the Company's fiscal year ended December 31, 2012, File No. 000-19364] |
|                                        |   |                                                                                                                                                                                                                                            |
| 10.20                                       |   | Amended and Restated Employment Agreement dated November 30, 2012 between the Company and Alfred Lumsdaine [incorporated by reference to Exhibit 10.6 to Form 10-K for the Company's fiscal year ended December 31, 2012, File No. 000-19364]   |
|                                        |   |                                                                                                                                                                                                                                            |
| 10.21                                       |   | Employment Agreement dated August 31, 2011 between the Company and Michael R. Farris [incorporated by reference to Exhibit 10.12 to Form 10-K for the Company's fiscal year ended December 31, 2011, File No. 000-19364]                        |

----

| 10.22  |   | Amendment to Employment Agreement dated December 1, 2012 between the Company and Michael R. Farris [incorporated by reference to Exhibit 10.10 to Form 10-K for the Company's fiscal year ended December 31, 2012, File No. 000-19364]       |
|--------|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |   |                                                                                                                                                                                                                                         |
| 10.23  |   | Employment Agreement dated January 1, 2012 between the Company and Peter Choueiri [incorporated by reference to Exhibit 10.1 to Form 10-Q of the Company's fiscal quarter ended March 31, 2012, File No. 000-19364]                          |
|   |   |                                                                                                                                                                                                                                         |
| 10.24  |   | Employment Agreement dated July 29, 2012 between the Company and Glenn Hargreaves [incorporated by reference to Exhibit 10.1 to Form 10-Q of the Company's fiscal quarter ended June 30, 2012, File No. 000-19364]                           |
|   |   |                                                                                                                                                                                                                                         |
| 10.25  |   | Employment Agreement dated July 29, 2012 between the Company and Mary Flipse [incorporated by reference to Exhibit 10.2 to Form 10-Q of the Company's fiscal quarter ended June 30, 2012, File No. 000-19364]                                |
|   |   |                                                                                                                                                                                                                                         |
| 10.26  |   | Amended and Restated Corporate and Subsidiary Capital Accumulation Plan [incorporated by reference to Exhibit 10.2 to Form 10-Q of the Company's fiscal quarter ended June 30, 2011, File No. 000-19364]                                     |
|   |   |                                                                                                                                                                                                                                         |
| 10.27  |   | Form of Indemnification Agreement by and among the Company and the Company's directors [incorporated by reference to Exhibit 10.15 to Registration Statement on Form S-1 (Registration No. 33-41119)]                                        |
|   |   |                                                                                                                                                                                                                                         |
| 10.28  |   | 2007 Stock Incentive Plan, as amended [incorporated by reference to Exhibit 10.16 to Form 10-K for the Company's fiscal year ended December 31, 2012, File No. 000-19364]                                                               |
| 10.29  |   | 1996 Stock Incentive Plan, as amended  [incorporated by reference to Exhibit 10.20 to Form 10-K for the Company's fiscal year ended August 31, 2006, File No. 000-19364]                                                                |
|   |   |                                                                                                                                                                                                                                         |
| 10.30  |   | Amended and Restated 2001 Stock Option Plan  [incorporated by reference to Exhibit 10.21 to Form 10-K for the Company's fiscal year ended August 31, 2006, File No. 000-19364]                                                          |
|   |   |                                                                                                                                                                                                                                         |
| 10.31  |   | Form of Non-Qualified Stock Option Agreement under the Company's 2007 Stock Incentive Plan [incorporated by reference to Exhibit 10.24 to Form 10-K for the Company's fiscal year ended August 31, 2007, File No. 000-19364]                 |
|   |   |                                                                                                                                                                                                                                         |
| 10.32  |   | Form of Restricted Stock Unit Award Agreement under the Company's 2007 Stock Incentive Plan [incorporated by reference to Exhibit 10.25 to Form 10-K for the Company's fiscal year ended August 31, 2007, File No. 000-19364]                |
|   |   |                                                                                                                                                                                                                                         |
| 10.33  |   | Form of Non-Qualified Stock Option Agreement (for Directors) under the Company's 2007 Stock Incentive Plan [incorporated by reference to Exhibit 10.2 to Form 10-Q of the Company's fiscal quarter ended June 30, 2010, File No. 000-19364]  |
|   |   |                                                                                                                                                                                                                                         |
| 10.34  |   | Form of Restricted Stock Unit Award Agreement (for Directors) under the Company's 2007 Stock Incentive Plan [incorporated by reference to Exhibit 10.3 to Form 10-Q of the Company's fiscal quarter ended June 30, 2010, File No. 000-19364] |
|   |   |                                                                                                                                                                                                                                         |
| 10.35  |   | 2007 Stock Incentive Plan Performance Cash Award Agreement dated March 3, 2009 [incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K dated March 4, 2009, File No. 000-19364]                               |
|   |   |                                                                                                                                                                                                                                         |
| 10.36  |   | 2007 Stock Incentive Plan Performance Cash Award Agreement dated May 25, 2011 [incorporated by reference to Exhibit 10.3 to Form 10-Q of the Company's fiscal quarter ended June 30, 2011, File No. 000-19364]                               |

----

|   |   |                                                                                                                                                                                                                                 |
|--------|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 10.37  |   | Form of Non-Qualified Stock Option Agreement under the Company's 2007 Stock Incentive Plan [incorporated by reference to Exhibit 10.2 to Form 10-Q of the Company's fiscal quarter ended March 31, 2012, File No. 000-19364]         |
|   |   |                                                                                                                                                                                                                                 |
| 10.38  |   | Form of Restricted Stock Unit Award Agreement under the Company's 2007 Stock Incentive Plan [incorporated by reference to Exhibit 10.3 to Form 10-Q of the Company's fiscal quarter ended March 31, 2012, File No. 000-19364]   |
|   |   |                                                                                                                                                                                                                                 |
| 10.39  |   | 2007 Stock Incentive Plan Performance Cash Award Agreement dated January 18, 2012 [incorporated by reference to Exhibit 10.4 to Form 10-Q of the Company's fiscal quarter ended March 31, 2012, File No. 000-19364]                  |
|   |   |                                                                                                                                                                                                                                 |
| 10.40  |   | Form of Non-Qualified Stock Option Agreement under the Company's 2007 Stock Incentive Plan [incorporated by reference to Exhibit 10.28 to Form 10-K for the Company's fiscal year ended December 31, 2012, File No. 000-19364]  |
|   |   |                                                                                                                                                                                                                                 |
| 10.41  |   | Form of Restricted Stock Unit Award Agreement under the Company's 2007 Stock Incentive Plan [incorporated by reference to Exhibit 10.29 to Form 10-K for the Company's fiscal year ended December 31, 2012, File No. 000-19364] |
|   |   |                                                                                                                                                                                                                                 |
| 10.42  |   | 2007 Stock Incentive Plan Performance Cash Award Agreement dated February 28, 2013 [incorporated by reference to Exhibit 10.30 to Form 10-K for the Company's fiscal year ended December 31, 2012, File No. 000-19364]               |
| 10.43  |   | 2007 Stock Incentive Plan Performance Cash Award Agreement for Peter Choueiri dated February 28, 2013 [incorporated by reference to Exhibit 10.31 to Form 10-K for the Company's fiscal year ended December 31, 2012, File No. 000-19364]                      |
|--------|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |   |                                                                                                                                                                                                                                                           |
| 14.1   |   | Code of Business Conduct of Healthways, Inc. [incorporated by reference to Exhibit 14.1 to the Company's Current Report on Form 8-K dated August 12, 2011, File No. 000-19364]                                                                            |
| 21     |   | Subsidiary List [incorporated by reference to Exhibit 21 to Form 10-K for the Company's fiscal year ended December 31, 2013, File No. 000-19364]                                                                                                               |
|   |   |                                                                                                                                                                                                                                                           |
| 23     |   | Consent of Ernst & Young LLP [incorporated by reference to Exhibit 23 to Form 10-K for the Company's fiscal year ended December 31, 2013, File No. 000-19364]                                                                                              |
|   |   |                                                                                                                                                                                                                                                           |
| 31.1   |   | Certification pursuant to section 302 of the Sarbanes-Oxley Act of 2002 made by Ben R. Leedle, Jr., Chief Executive Officer [incorporated by reference to Exhibit 31.1 to Form 10-K for the Company's fiscal year ended December 31, 2013, File No. 000-19364] |
|   |   |                                                                                                                                                                                                                                                           |
| 31.2   |   | Certification pursuant to section 302 of the Sarbanes-Oxley Act of 2002 made by Alfred Lumsdaine, Chief Financial Officer [incorporated by reference to Exhibit 31.2 to Form 10-K for the Company's fiscal year ended December 31, 2013, File No. 000-19364]   |
|   |   |                                                                                                                                                                                                                                                           |
| 31.3   |   | Certification pursuant to section 302 of the Sarbanes-Oxley Act of 2002 made by Ben R. Leedle, Jr., Chief Executive Officer                                                                                                                                    |
|   |   |                                                                                                                                                                                                                                                           |
| 31.4   |   | Certification pursuant to section 302 of the Sarbanes-Oxley Act of 2002 made by Alfred Lumsdaine, Chief Financial Officer                                                                                                                                      |

----

|   |   |                                                                                                                                                                                                                                                                                                                                                     |
|--------|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 32     |   | Certification Pursuant to 18 U.S.C section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 made by Ben R. Leedle, Jr., Chief Executive Officer, and Alfred Lumsdaine, Chief Financial Officer [incorporated by reference to Exhibit 32 to Form 10-K for the Company's fiscal year ended December 31, 2013, File No. 000-19364] |
|   |   |                                                                                                                                                                                                                                                                                                                                                     |
|   |   | *Portions of this Exhibit have been omitted and filed separately with the U.S. Securities and Exchange Commission as part of an application for confidential treatment pursuant to the Securities Exchange Act of 1934.                                                                                                                                  |

| (b) | Exhibits |
|-----|----------|

| (c) | Not applicable |
|-----|----------------|

----

|           |   | HEALTHWAYS, INC |
|----------------|--------|-----------------|
|           |   |            |   |
| April 30, 2014 |   | By:             | /s/ Ben R. Leedle, Jr. |
|           |   |            | Ben R. Leedle, Jr. |
|           |   |            | Chief Executive Officer |

----